| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.13e-45 | 46 | 39 | 20 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.27e-31 | 188 | 39 | 20 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.45e-17 | 891 | 39 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.71e-11 | 12 | 39 | 5 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 1.83e-06 | 192 | 39 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.24e-05 | 268 | 39 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.27e-05 | 156 | 39 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.35e-05 | 86 | 39 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.56e-05 | 323 | 39 | 6 | GO:1901681 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL27A1 COL1A1 COL1A2 | 2.26e-20 | 377 | 37 | 17 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL27A1 COL1A1 COL1A2 | 2.36e-20 | 378 | 37 | 17 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL27A1 COL1A1 COL1A2 | 2.47e-20 | 379 | 37 | 17 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 8.78e-15 | 76 | 37 | 9 | GO:0030199 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 4.29e-09 | 12 | 37 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.63e-08 | 18 | 37 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL3A1 COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL11A2 ANKRD23 COL27A1 COL1A1 COL1A2 | 5.70e-07 | 957 | 37 | 11 | GO:0097435 |
| GeneOntologyBiologicalProcess | skeletal system development | COL3A1 COL5A2 COL9A2 COL11A1 COL11A2 COL13A1 COL27A1 COL1A1 COL1A2 | 1.04e-06 | 615 | 37 | 9 | GO:0001501 |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 9.11e-06 | 277 | 37 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 9.70e-06 | 161 | 37 | 5 | GO:0071230 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 1.20e-05 | 79 | 37 | 4 | GO:0060350 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 1.53e-05 | 177 | 37 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | response to amino acid | 2.90e-05 | 202 | 37 | 5 | GO:0043200 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.92e-05 | 929 | 37 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | connective tissue development | 3.05e-05 | 343 | 37 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | vasculature development | 4.06e-05 | 969 | 37 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 4.68e-05 | 6 | 37 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | skin development | 4.86e-05 | 373 | 37 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 5.16e-05 | 228 | 37 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL3A1 COL5A1 COL5A2 FLNA COL11A1 COL11A2 COL13A1 COL27A1 COL1A1 COL1A2 | 5.66e-05 | 1269 | 37 | 10 | GO:0009887 |
| GeneOntologyBiologicalProcess | tendon development | 6.54e-05 | 7 | 37 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | cartilage development | 6.98e-05 | 243 | 37 | 5 | GO:0051216 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 7.05e-05 | 124 | 37 | 4 | GO:0060349 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 9.25e-05 | 133 | 37 | 4 | GO:0002062 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 1.40e-04 | 10 | 37 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL3A1 COL4A1 COL4A2 COL5A1 FLNA JUNB COL11A1 COL27A1 COL1A1 COL1A2 | 1.64e-04 | 1442 | 37 | 10 | GO:0072359 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA JUNB ANKRD23 COL27A1 COL1A1 | 2.07e-04 | 1483 | 37 | 10 | GO:0048646 |
| GeneOntologyBiologicalProcess | skin morphogenesis | 3.24e-04 | 15 | 37 | 2 | GO:0043589 | |
| GeneOntologyBiologicalProcess | ossification | 4.51e-04 | 562 | 37 | 6 | GO:0001503 | |
| GeneOntologyBiologicalProcess | protein trimerization | 5.83e-04 | 20 | 37 | 2 | GO:0070206 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 7.82e-04 | 410 | 37 | 5 | GO:0031589 | |
| GeneOntologyBiologicalProcess | bone development | 1.24e-03 | 264 | 37 | 4 | GO:0060348 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.58e-44 | 88 | 38 | 22 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 3.21e-35 | 21 | 38 | 14 | GO:0098644 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 ITLN2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.68e-26 | 530 | 38 | 22 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.05e-24 | 332 | 38 | 19 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 ITLN2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.31e-24 | 656 | 38 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 ITLN2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.88e-24 | 658 | 38 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.70e-23 | 12 | 38 | 9 | GO:0005583 |
| GeneOntologyCellularComponent | banded collagen fibril | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.70e-23 | 12 | 38 | 9 | GO:0098643 |
| GeneOntologyCellularComponent | collagen type XI trimer | 4.63e-11 | 5 | 38 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL11A2 ANKRD23 COL27A1 AHNAK2 COL1A1 COL1A2 | 7.18e-11 | 1187 | 38 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.39e-10 | 6 | 38 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 6.46e-10 | 8 | 38 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 6.46e-10 | 8 | 38 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 6.46e-10 | 8 | 38 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type V trimer | 2.21e-08 | 4 | 38 | 3 | GO:0005588 | |
| GeneOntologyCellularComponent | basement membrane | 8.27e-08 | 122 | 38 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL3A1 COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL11A2 ANKRD23 COL27A1 AHNAK2 COL1A1 COL1A2 | 6.75e-07 | 1179 | 38 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | collagen type I trimer | 3.22e-06 | 2 | 38 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | I band | 3.38e-03 | 166 | 38 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | T-tubule | 9.08e-03 | 79 | 38 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | sarcomere | 1.04e-02 | 249 | 38 | 3 | GO:0030017 | |
| HumanPheno | Arterial rupture | 5.13e-11 | 8 | 22 | 5 | HP:0025019 | |
| HumanPheno | Cervical insufficiency | 2.61e-10 | 4 | 22 | 4 | HP:0030009 | |
| HumanPheno | Osteoarthritis | 5.81e-09 | 65 | 22 | 7 | HP:0002758 | |
| HumanPheno | Atrophic scars | 6.59e-09 | 37 | 22 | 6 | HP:0001075 | |
| HumanPheno | Fragile skin | 6.59e-09 | 37 | 22 | 6 | HP:0001030 | |
| HumanPheno | Molluscoid pseudotumors | 9.06e-09 | 7 | 22 | 4 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 9.06e-09 | 7 | 22 | 4 | HP:0000139 | |
| HumanPheno | Shoulder dislocation | 1.37e-08 | 20 | 22 | 5 | HP:0003834 | |
| HumanPheno | Atypical scarring of skin | 1.47e-08 | 74 | 22 | 7 | HP:0000987 | |
| HumanPheno | Genital hernia | 1.81e-08 | 8 | 22 | 4 | HP:0100823 | |
| HumanPheno | Cigarette-paper scars | 5.39e-08 | 10 | 22 | 4 | HP:0001073 | |
| HumanPheno | Subcutaneous spheroids | 6.99e-08 | 3 | 22 | 3 | HP:0025014 | |
| HumanPheno | Arterial dissection | 1.26e-07 | 12 | 22 | 4 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 1.26e-07 | 12 | 22 | 4 | HP:0004947 | |
| HumanPheno | Scarring | 1.40e-07 | 102 | 22 | 7 | HP:0100699 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.82e-07 | 13 | 22 | 4 | HP:0012888 | |
| HumanPheno | Tricuspid valve prolapse | 2.54e-07 | 14 | 22 | 4 | HP:0001704 | |
| HumanPheno | Soft, doughy skin | 2.54e-07 | 14 | 22 | 4 | HP:0001027 | |
| HumanPheno | Piezogenic pedal papules | 2.79e-07 | 4 | 22 | 3 | HP:0025509 | |
| HumanPheno | Incisional hernia | 2.79e-07 | 4 | 22 | 3 | HP:0004872 | |
| HumanPheno | Bladder diverticulum | 3.19e-07 | 36 | 22 | 5 | HP:0000015 | |
| HumanPheno | Premature rupture of membranes | 5.99e-07 | 17 | 22 | 4 | HP:0001788 | |
| HumanPheno | Hip dislocation | COL3A1 COL5A1 COL5A2 FLNA COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 6.26e-07 | 263 | 22 | 9 | HP:0002827 |
| HumanPheno | Dilatation of the ascending aorta | 1.01e-06 | 84 | 22 | 6 | HP:0005111 | |
| HumanPheno | Dilatation of the cerebral artery | 1.91e-06 | 51 | 22 | 5 | HP:0004944 | |
| HumanPheno | Upper extremity joint dislocation | 2.24e-06 | 96 | 22 | 6 | HP:0030310 | |
| HumanPheno | Pulp calcification | 2.42e-06 | 7 | 22 | 3 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 2.42e-06 | 7 | 22 | 3 | HP:0006243 | |
| HumanPheno | Dislocated radial head | 2.55e-06 | 54 | 22 | 5 | HP:0003083 | |
| HumanPheno | Lower extremity joint dislocation | COL3A1 COL5A1 COL5A2 FLNA COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 3.10e-06 | 318 | 22 | 9 | HP:0030311 |
| HumanPheno | Abnormality of the radial head | 3.34e-06 | 57 | 22 | 5 | HP:0003995 | |
| HumanPheno | Limb pain | 3.34e-06 | 57 | 22 | 5 | HP:0009763 | |
| HumanPheno | Abnormal hip bone morphology | COL3A1 COL5A1 COL5A2 FLNA COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 3.39e-06 | 653 | 22 | 12 | HP:0003272 |
| HumanPheno | Abnormal forearm morphology | 3.77e-06 | 239 | 22 | 8 | HP:0002973 | |
| HumanPheno | Blepharochalasis | 3.86e-06 | 8 | 22 | 3 | HP:0010749 | |
| HumanPheno | Dermal atrophy | 4.24e-06 | 107 | 22 | 6 | HP:0004334 | |
| HumanPheno | Abnormal tibia morphology | 4.24e-06 | 107 | 22 | 6 | HP:0002992 | |
| HumanPheno | Dermal translucency | 4.29e-06 | 27 | 22 | 4 | HP:0010648 | |
| HumanPheno | Abnormality of the humeroradial joint | 5.09e-06 | 62 | 22 | 5 | HP:0100744 | |
| HumanPheno | Arthritis | 5.45e-06 | 251 | 22 | 8 | HP:0001369 | |
| HumanPheno | Myopia | COL4A1 COL4A4 COL4A5 COL5A1 FLNA COL9A2 COL11A1 COL11A2 SLC39A5 COL1A2 | 6.03e-06 | 447 | 22 | 10 | HP:0000545 |
| HumanPheno | Abnormality of upper limb joint | COL5A1 COL5A2 FLNA COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 7.70e-06 | 705 | 22 | 12 | HP:0009810 |
| HumanPheno | Abnormality of refraction | COL3A1 COL4A1 COL4A4 COL4A5 COL5A1 FLNA COL9A2 COL11A1 COL11A2 COL25A1 SLC39A5 COL1A2 | 8.18e-06 | 709 | 22 | 12 | HP:0000539 |
| HumanPheno | Thoracic aortic aneurysm | 8.67e-06 | 121 | 22 | 6 | HP:0012727 | |
| HumanPheno | Small joint hypermobilty | 8.67e-06 | 69 | 22 | 5 | HP:0430046 | |
| HumanPheno | Aortic root aneurysm | 9.32e-06 | 70 | 22 | 5 | HP:0002616 | |
| HumanPheno | Mitral valve prolapse | 9.54e-06 | 123 | 22 | 6 | HP:0001634 | |
| HumanPheno | Bell-shaped thorax | 9.84e-06 | 33 | 22 | 4 | HP:0001591 | |
| HumanPheno | Platyspondyly | 9.99e-06 | 124 | 22 | 6 | HP:0000926 | |
| HumanPheno | Abdominal aortic aneurysm | 1.05e-05 | 125 | 22 | 6 | HP:0005112 | |
| HumanPheno | Pierre-Robin sequence | 1.11e-05 | 34 | 22 | 4 | HP:0000201 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL3A1 COL5A1 COL5A2 FLNA COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 1.12e-05 | 730 | 22 | 12 | HP:0002644 |
| HumanPheno | Abnormality of the elbow | 1.29e-05 | 282 | 22 | 8 | HP:0009811 | |
| HumanPheno | Abnormal cornea morphology | COL3A1 COL4A1 COL4A4 COL4A5 COL5A1 COL5A2 FLNA COL7A1 COL9A2 COL11A1 COL1A1 COL1A2 | 1.36e-05 | 744 | 22 | 12 | HP:0000481 |
| HumanPheno | Abnormal hip joint morphology | COL3A1 COL5A1 COL5A2 FLNA COL9A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 1.38e-05 | 490 | 22 | 10 | HP:0001384 |
| HumanPheno | Abnormal femoral neck/head morphology | 1.38e-05 | 201 | 22 | 7 | HP:0003366 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 1.38e-05 | 201 | 22 | 7 | HP:0008065 | |
| HumanPheno | Dermatochalasis | 1.50e-05 | 12 | 22 | 3 | HP:0010750 | |
| HumanPheno | Joint dislocation | COL3A1 COL5A1 COL5A2 FLNA COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 1.67e-05 | 390 | 22 | 9 | HP:0001373 |
| HumanPheno | Abnormal synovial membrane morphology | COL3A1 COL5A1 COL5A2 FLNA COL9A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 1.74e-05 | 503 | 22 | 10 | HP:0005262 |
| HumanPheno | Biconcave flattened vertebrae | 1.78e-05 | 2 | 22 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 1.78e-05 | 2 | 22 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 1.78e-05 | 2 | 22 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 1.78e-05 | 2 | 22 | 2 | HP:0005005 | |
| HumanPheno | Abnormal limb epiphysis morphology | 1.85e-05 | 138 | 22 | 6 | HP:0006505 | |
| HumanPheno | Vascular dilatation | 2.15e-05 | 215 | 22 | 7 | HP:0002617 | |
| HumanPheno | Abnormal morphology of the radius | 2.28e-05 | 217 | 22 | 7 | HP:0002818 | |
| HumanPheno | Elbow dislocation | 2.28e-05 | 84 | 22 | 5 | HP:0003042 | |
| HumanPheno | Congenital hip dislocation | 2.28e-05 | 84 | 22 | 5 | HP:0001374 | |
| HumanPheno | Tibial bowing | 2.38e-05 | 41 | 22 | 4 | HP:0002982 | |
| HumanPheno | Abnormal delivery | 2.46e-05 | 145 | 22 | 6 | HP:0001787 | |
| HumanPheno | Recurrent joint dislocation | 2.47e-05 | 14 | 22 | 3 | HP:0031869 | |
| HumanPheno | Abnormal mitral valve morphology | 2.55e-05 | 146 | 22 | 6 | HP:0031477 | |
| HumanPheno | Soft skin | 3.16e-05 | 44 | 22 | 4 | HP:0000977 | |
| HumanPheno | Thin skin | 3.20e-05 | 90 | 22 | 5 | HP:0000963 | |
| HumanPheno | Coxa valga | 3.56e-05 | 92 | 22 | 5 | HP:0002673 | |
| HumanPheno | Abnormal forearm bone morphology | 3.93e-05 | 236 | 22 | 7 | HP:0040072 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 3.95e-05 | 94 | 22 | 5 | HP:0006500 | |
| HumanPheno | Enlarged thorax | 3.95e-05 | 94 | 22 | 5 | HP:0100625 | |
| HumanPheno | Subcutaneous nodule | 4.16e-05 | 95 | 22 | 5 | HP:0001482 | |
| HumanPheno | Abnormal femoral neck morphology | 4.30e-05 | 160 | 22 | 6 | HP:0003367 | |
| HumanPheno | Hyperextensible skin | 4.61e-05 | 162 | 22 | 6 | HP:0000974 | |
| HumanPheno | Wide anterior fontanel | 5.08e-05 | 99 | 22 | 5 | HP:0000260 | |
| HumanPheno | Hip dysplasia | 5.28e-05 | 247 | 22 | 7 | HP:0001385 | |
| HumanPheno | Femoral bowing | 5.28e-05 | 50 | 22 | 4 | HP:0002980 | |
| HumanPheno | Glomerular basement membrane lamellation | 5.33e-05 | 3 | 22 | 2 | HP:0030034 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 5.33e-05 | 3 | 22 | 2 | HP:0006201 | |
| HumanPheno | Anterior lenticonus | 5.33e-05 | 3 | 22 | 2 | HP:0011501 | |
| HumanPheno | Popcorn calcification | 5.33e-05 | 3 | 22 | 2 | HP:6000871 | |
| HumanPheno | Aortic dilatation | 5.66e-05 | 168 | 22 | 6 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 5.66e-05 | 168 | 22 | 6 | HP:0004942 | |
| HumanPheno | Finger joint hypermobility | 6.17e-05 | 52 | 22 | 4 | HP:0006094 | |
| HumanPheno | Poor wound healing | 6.17e-05 | 52 | 22 | 4 | HP:0001058 | |
| HumanPheno | Abnormality of the temporomandibular joint | 6.48e-05 | 19 | 22 | 3 | HP:0010754 | |
| HumanPheno | Abnormal tricuspid valve morphology | 6.74e-05 | 105 | 22 | 5 | HP:0031440 | |
| HumanPheno | Abnormality of lower limb joint | COL3A1 COL5A1 COL5A2 FLNA COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 6.79e-05 | 1027 | 22 | 13 | HP:0100491 |
| HumanPheno | Flat face | 7.05e-05 | 106 | 22 | 5 | HP:0012368 | |
| HumanPheno | Premature birth | 7.59e-05 | 177 | 22 | 6 | HP:0001622 | |
| HumanPheno | Glomerular deposits | 7.60e-05 | 20 | 22 | 3 | HP:0030949 | |
| HumanPheno | Joint laxity | 7.70e-05 | 55 | 22 | 4 | HP:0001388 | |
| MousePheno | abnormal dermal layer morphology | 2.09e-07 | 108 | 34 | 6 | MP:0001243 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 4.92e-07 | 27 | 34 | 4 | MP:0008438 | |
| MousePheno | abnormal synovial joint morphology | 1.15e-05 | 124 | 34 | 5 | MP:0030804 | |
| MousePheno | hematuria | 1.24e-05 | 19 | 34 | 3 | MP:0005161 | |
| MousePheno | abnormal aorta morphology | 1.50e-05 | 225 | 34 | 6 | MP:0000272 | |
| MousePheno | abnormal long bone morphology | COL7A1 COL9A2 COL11A1 COL11A2 ITLN2 XRCC5 COL27A1 COL1A1 COL1A2 | 2.42e-05 | 676 | 34 | 9 | MP:0003723 |
| MousePheno | decreased skin tensile strength | 3.29e-05 | 26 | 34 | 3 | MP:0003089 | |
| MousePheno | buphthalmos | 3.43e-05 | 4 | 34 | 2 | MP:0009274 | |
| MousePheno | abnormal appendicular skeleton morphology | FLNA COL7A1 COL9A2 COL11A1 COL11A2 ITLN2 XRCC5 COL27A1 COL1A1 COL1A2 | 3.55e-05 | 896 | 34 | 10 | MP:0009250 |
| MousePheno | abnormal compact bone lamellar structure | 5.72e-05 | 5 | 34 | 2 | MP:0010970 | |
| MousePheno | renal glomerular synechia | 5.72e-05 | 5 | 34 | 2 | MP:0011483 | |
| MousePheno | decreased tendon stiffness | 5.72e-05 | 5 | 34 | 2 | MP:0003098 | |
| MousePheno | anterior polar cataract | 5.72e-05 | 5 | 34 | 2 | MP:0010259 | |
| MousePheno | abnormal skin tensile strength | 6.21e-05 | 32 | 34 | 3 | MP:0005275 | |
| MousePheno | abnormal systemic artery morphology | 8.10e-05 | 304 | 34 | 6 | MP:0011655 | |
| MousePheno | abnormal tendon physiology | 8.56e-05 | 6 | 34 | 2 | MP:0030802 | |
| MousePheno | abnormal tendon stiffness | 8.56e-05 | 6 | 34 | 2 | MP:0003097 | |
| MousePheno | polar cataract | 8.56e-05 | 6 | 34 | 2 | MP:0010258 | |
| MousePheno | increased bone mineral density | 9.81e-05 | 194 | 34 | 5 | MP:0000062 | |
| MousePheno | podocyte foot process effacement | 1.05e-04 | 38 | 34 | 3 | MP:0008140 | |
| MousePheno | abnormal blood vessel morphology | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 FLNA DOT1L XRCC5 PRDM6 COL27A1 COL1A1 | 1.07e-04 | 1472 | 34 | 12 | MP:0001614 |
| MousePheno | abnormal limb morphology | COL4A2 COL7A1 COL9A2 COL11A1 COL13A1 ITLN2 XRCC5 COL27A1 COL1A1 COL1A2 | 1.14e-04 | 1028 | 34 | 10 | MP:0002109 |
| MousePheno | limbs/digits/tail phenotype | COL4A2 COL7A1 COL9A2 COL11A1 COL13A1 ITLN2 DOT1L XRCC5 COL27A1 COL1A1 COL1A2 | 1.23e-04 | 1258 | 34 | 11 | MP:0005371 |
| MousePheno | macrophthalmia | 1.59e-04 | 8 | 34 | 2 | MP:0001296 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.63e-04 | 44 | 34 | 3 | MP:0011348 | |
| MousePheno | aortic dissection | 2.05e-04 | 9 | 34 | 2 | MP:0004044 | |
| MousePheno | abnormal knee joint morphology | 2.05e-04 | 9 | 34 | 2 | MP:0030837 | |
| MousePheno | dilated glomerular capillary | 2.05e-04 | 9 | 34 | 2 | MP:0011509 | |
| MousePheno | decreased circulating protein level | 2.12e-04 | 698 | 34 | 8 | MP:0014502 | |
| MousePheno | decreased collagen level | 3.12e-04 | 11 | 34 | 2 | MP:0020254 | |
| MousePheno | abnormal podocyte foot process morphology | 3.16e-04 | 55 | 34 | 3 | MP:0008059 | |
| MousePheno | abnormal joint morphology | 3.46e-04 | 397 | 34 | 6 | MP:0002932 | |
| MousePheno | increased bone mineral content | 3.70e-04 | 258 | 34 | 5 | MP:0010123 | |
| MousePheno | increased circulating protein level | COL4A1 BNC1 COL4A5 COL9A2 C1QTNF3 COL11A2 ITLN2 XRCC5 SLC39A5 ZCCHC3 COL1A2 | 3.89e-04 | 1433 | 34 | 11 | MP:0014501 |
| MousePheno | dilated capillary | 4.40e-04 | 13 | 34 | 2 | MP:0020326 | |
| MousePheno | total cataract | 4.40e-04 | 13 | 34 | 2 | MP:0010263 | |
| MousePheno | albuminuria | 4.73e-04 | 63 | 34 | 3 | MP:0002871 | |
| MousePheno | scoliosis | 4.95e-04 | 64 | 34 | 3 | MP:0000161 | |
| MousePheno | abnormal digestive system morphology | COL3A1 COL4A2 COL4A4 FLNA COL7A1 GCGR COL11A1 SLC39A5 COL27A1 COL1A1 | 5.02e-04 | 1233 | 34 | 10 | MP:0000462 |
| MousePheno | absent T cells | 5.13e-04 | 14 | 34 | 2 | MP:0008070 | |
| MousePheno | abnormal osteocyte morphology | 5.91e-04 | 15 | 34 | 2 | MP:0008753 | |
| MousePheno | abnormal artery morphology | 5.98e-04 | 440 | 34 | 6 | MP:0002191 | |
| MousePheno | abnormal podocyte morphology | 6.44e-04 | 70 | 34 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 6.44e-04 | 70 | 34 | 3 | MP:0011497 | |
| MousePheno | decreased bone trabecula number | 6.44e-04 | 70 | 34 | 3 | MP:0010869 | |
| MousePheno | abnormal collagen level | 6.74e-04 | 16 | 34 | 2 | MP:0020252 | |
| MousePheno | decreased diameter of femur | 6.74e-04 | 16 | 34 | 2 | MP:0008152 | |
| MousePheno | abnormal joint mobility | 7.63e-04 | 17 | 34 | 2 | MP:0008069 | |
| MousePheno | aorta stenosis | 7.63e-04 | 17 | 34 | 2 | MP:0010463 | |
| MousePheno | abnormal blood circulation | 7.66e-04 | 845 | 34 | 8 | MP:0002128 | |
| MousePheno | increased inflammatory response | COL3A1 COL4A1 COL4A4 COL4A5 C1QTNF3 COL11A1 COL13A1 SLC39A5 COL1A1 | 8.32e-04 | 1077 | 34 | 9 | MP:0001846 |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 8.57e-04 | 18 | 34 | 2 | MP:0030485 | |
| MousePheno | postnatal lethality | 8.72e-04 | 1084 | 34 | 9 | MP:0002082 | |
| MousePheno | abnormal hypodermis morphology | 9.31e-04 | 181 | 34 | 4 | MP:0003705 | |
| MousePheno | abnormal pancreas weight | 9.57e-04 | 19 | 34 | 2 | MP:0009107 | |
| MousePheno | postnatal lethality, incomplete penetrance | 9.67e-04 | 669 | 34 | 7 | MP:0011086 | |
| MousePheno | abnormal chondrocyte morphology | 1.06e-03 | 83 | 34 | 3 | MP:0000166 | |
| MousePheno | abnormal glomerular mesangium morphology | 1.06e-03 | 83 | 34 | 3 | MP:0011339 | |
| MousePheno | lens vacuoles | 1.06e-03 | 20 | 34 | 2 | MP:0011697 | |
| MousePheno | abnormal hindlimb joint morphology | 1.06e-03 | 20 | 34 | 2 | MP:0030808 | |
| MousePheno | thin dermal layer | 1.06e-03 | 20 | 34 | 2 | MP:0001244 | |
| MousePheno | abnormal lens capsule morphology | 1.06e-03 | 20 | 34 | 2 | MP:0003236 | |
| MousePheno | osteoarthritis | 1.17e-03 | 21 | 34 | 2 | MP:0003560 | |
| MousePheno | abnormal bone structure | RABL6 BNC1 COL7A1 GCGR COL11A1 ITLN2 SLC39A5 COL27A1 COL1A1 COL1A2 | 1.21e-03 | 1379 | 34 | 10 | MP:0003795 |
| MousePheno | abnormal circulating serum albumin level | 1.22e-03 | 336 | 34 | 5 | MP:0000199 | |
| MousePheno | thick dermal layer | 1.29e-03 | 22 | 34 | 2 | MP:0001245 | |
| MousePheno | abnormal aorta elastic tissue morphology | 1.29e-03 | 22 | 34 | 2 | MP:0009862 | |
| MousePheno | abnormal knee morphology | 1.41e-03 | 23 | 34 | 2 | MP:0030881 | |
| MousePheno | decreased diameter of long bones | 1.41e-03 | 23 | 34 | 2 | MP:0008150 | |
| MousePheno | tubulointerstitial nephritis | 1.53e-03 | 24 | 34 | 2 | MP:0011405 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 1.53e-03 | 24 | 34 | 2 | MP:0006083 | |
| MousePheno | increased bone trabecular spacing | 1.66e-03 | 25 | 34 | 2 | MP:0013630 | |
| MousePheno | abnormal limb joint morphology | 1.66e-03 | 25 | 34 | 2 | MP:0030805 | |
| MousePheno | abnormal femur morphology | 1.73e-03 | 214 | 34 | 4 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 1.76e-03 | 215 | 34 | 4 | MP:0003856 | |
| MousePheno | abnormal long bone diaphysis morphology | 1.80e-03 | 26 | 34 | 2 | MP:0004214 | |
| MousePheno | fragile skeleton | 1.80e-03 | 26 | 34 | 2 | MP:0000061 | |
| MousePheno | abnormal pancreas morphology | 1.80e-03 | 367 | 34 | 5 | MP:0001944 | |
| MousePheno | abnormal extracellular matrix morphology | 1.81e-03 | 100 | 34 | 3 | MP:0013258 | |
| MousePheno | decreased bone volume | 1.81e-03 | 100 | 34 | 3 | MP:0010876 | |
| MousePheno | dilated renal tubule | 1.86e-03 | 101 | 34 | 3 | MP:0002705 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 1.94e-03 | 27 | 34 | 2 | MP:0011409 | |
| MousePheno | abnormal heart ventricle size | 2.18e-03 | 228 | 34 | 4 | MP:0031543 | |
| MousePheno | abnormal renal glomerular capsule morphology | 2.20e-03 | 107 | 34 | 3 | MP:0002828 | |
| MousePheno | kyphosis | 2.21e-03 | 229 | 34 | 4 | MP:0000160 | |
| MousePheno | digestive/alimentary phenotype | COL3A1 COL4A2 COL4A4 FLNA COL7A1 GCGR COL11A1 SLC39A5 COL27A1 COL1A1 | 2.30e-03 | 1500 | 34 | 10 | MP:0005381 |
| MousePheno | abnormal blood urea nitrogen level | 2.33e-03 | 389 | 34 | 5 | MP:0005265 | |
| MousePheno | renal tubule atrophy | 2.39e-03 | 30 | 34 | 2 | MP:0011346 | |
| MousePheno | abnormal hindlimb morphology | 2.39e-03 | 576 | 34 | 6 | MP:0000556 | |
| MousePheno | short limbs | 2.44e-03 | 111 | 34 | 3 | MP:0000547 | |
| MousePheno | decreased circulating serum albumin level | 2.54e-03 | 238 | 34 | 4 | MP:0005419 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 2.55e-03 | 31 | 34 | 2 | MP:0011349 | |
| MousePheno | abnormal tendon morphology | 2.55e-03 | 31 | 34 | 2 | MP:0005503 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | COL4A1 COL4A2 FLNA COL7A1 COL11A1 COL25A1 COL27A1 COL1A1 COL1A2 | 2.64e-03 | 1269 | 34 | 9 | MP:0011111 |
| MousePheno | abnormal tail morphology | 2.71e-03 | 403 | 34 | 5 | MP:0002111 | |
| MousePheno | abnormal respiration | 2.89e-03 | 598 | 34 | 6 | MP:0001943 | |
| Domain | Collagen | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.47e-43 | 85 | 39 | 22 | PF01391 |
| Domain | Collagen | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.47e-43 | 85 | 39 | 22 | IPR008160 |
| Domain | Fib_collagen_C | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.53e-23 | 11 | 39 | 9 | IPR000885 |
| Domain | NC1_FIB | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.53e-23 | 11 | 39 | 9 | PS51461 |
| Domain | Fib_collagen_C | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.53e-23 | 11 | 39 | 9 | PD002078 |
| Domain | COLFI | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.53e-23 | 11 | 39 | 9 | SM00038 |
| Domain | COLFI | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.53e-23 | 11 | 39 | 9 | PF01410 |
| Domain | TSPN | 2.34e-14 | 23 | 39 | 7 | SM00210 | |
| Domain | Laminin_G | 2.73e-11 | 58 | 39 | 7 | IPR001791 | |
| Domain | C4 | 2.43e-10 | 6 | 39 | 4 | SM00111 | |
| Domain | - | 2.43e-10 | 6 | 39 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.43e-10 | 6 | 39 | 4 | IPR001442 | |
| Domain | NC1_IV | 2.43e-10 | 6 | 39 | 4 | PS51403 | |
| Domain | C4 | 2.43e-10 | 6 | 39 | 4 | PF01413 | |
| Domain | ConA-like_dom | 3.10e-07 | 219 | 39 | 7 | IPR013320 | |
| Domain | - | 4.41e-07 | 74 | 39 | 5 | 3.40.50.410 | |
| Domain | VWA | 8.33e-07 | 84 | 39 | 5 | SM00327 | |
| Domain | Laminin_G_2 | 1.41e-06 | 40 | 39 | 4 | PF02210 | |
| Domain | - | 1.54e-06 | 95 | 39 | 5 | 2.60.120.200 | |
| Domain | VWF_A | 1.89e-06 | 99 | 39 | 5 | IPR002035 | |
| Domain | LamG | 2.07e-06 | 44 | 39 | 4 | SM00282 | |
| Domain | VWA | 5.51e-06 | 56 | 39 | 4 | PF00092 | |
| Domain | VWFA | 2.53e-05 | 82 | 39 | 4 | PS50234 | |
| Domain | VWC | 2.66e-05 | 28 | 39 | 3 | PF00093 | |
| Domain | VWFC_1 | 5.73e-05 | 36 | 39 | 3 | PS01208 | |
| Domain | VWC | 6.75e-05 | 38 | 39 | 3 | SM00214 | |
| Domain | VWFC_2 | 6.75e-05 | 38 | 39 | 3 | PS50184 | |
| Domain | CTDL_fold | 7.18e-05 | 107 | 39 | 4 | IPR016187 | |
| Domain | VWF_dom | 9.13e-05 | 42 | 39 | 3 | IPR001007 | |
| Domain | - | 1.78e-03 | 30 | 39 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.78e-03 | 30 | 39 | 2 | IPR014716 | |
| Domain | C1Q | 2.03e-03 | 32 | 39 | 2 | SM00110 | |
| Domain | C1q | 2.03e-03 | 32 | 39 | 2 | PF00386 | |
| Domain | C1q_dom | 2.29e-03 | 34 | 39 | 2 | IPR001073 | |
| Domain | C1Q | 2.29e-03 | 34 | 39 | 2 | PS50871 | |
| Domain | LAM_G_DOMAIN | 2.85e-03 | 38 | 39 | 2 | PS50025 | |
| Domain | - | 4.89e-03 | 50 | 39 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.52e-03 | 58 | 39 | 2 | IPR008983 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.00e-44 | 44 | 32 | 20 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.23e-40 | 67 | 32 | 20 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 1.25e-39 | 41 | 32 | 18 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.79e-37 | 90 | 32 | 20 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 7.95e-36 | 61 | 32 | 18 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 7.49e-34 | 76 | 32 | 18 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 7.79e-33 | 64 | 32 | 17 | M26953 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 7.44e-32 | 53 | 32 | 16 | MM14566 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.01e-30 | 61 | 32 | 16 | M27103 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL1A1 COL1A2 | 9.34e-30 | 50 | 32 | 15 | MM14796 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 1.63e-26 | 140 | 32 | 17 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.46e-26 | 300 | 32 | 20 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 6.05e-26 | 114 | 32 | 16 | MM14571 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL3A1 COL4A1 COL4A4 COL4A5 COL5A1 COL5A2 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL1A1 COL1A2 | 2.45e-25 | 46 | 32 | 13 | M198 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 3.88e-25 | 32 | 32 | 12 | MM14924 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL13A1 COL1A1 COL1A2 | 2.16e-24 | 76 | 32 | 14 | MM14867 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL1A1 COL1A2 | 1.10e-23 | 258 | 32 | 18 | MM14572 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL13A1 COL1A1 COL1A2 | 1.18e-23 | 85 | 32 | 14 | M16441 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 1.38e-22 | 20 | 32 | 10 | MM15061 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL3A1 COL4A1 COL4A4 COL4A5 COL5A1 COL5A2 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL1A1 COL1A2 | 2.43e-22 | 74 | 32 | 13 | M160 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.86e-21 | 59 | 32 | 12 | M27218 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 COL1A1 COL1A2 | 5.03e-20 | 76 | 32 | 12 | M27219 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 3.44e-19 | 38 | 32 | 10 | MM14969 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 1.07e-18 | 42 | 32 | 10 | M7169 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL3A1 COL4A1 COL4A4 COL4A5 COL5A1 COL5A2 COL7A1 COL11A1 COL11A2 COL1A1 COL1A2 | 1.18e-18 | 66 | 32 | 11 | M18 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 6.44e-18 | 30 | 32 | 9 | M27772 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.99e-17 | 84 | 32 | 11 | M7098 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.03e-17 | 19 | 32 | 8 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 3.06e-17 | 57 | 32 | 10 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 3.69e-17 | 58 | 32 | 10 | M2049 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 8.98e-17 | 63 | 32 | 10 | M11187 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.55e-16 | 41 | 32 | 9 | M27778 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 9.76e-16 | 15 | 32 | 7 | M27161 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.54e-15 | 30 | 32 | 8 | MM15517 | |
| Pathway | WP_FOCAL_ADHESION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 3.73e-15 | 187 | 32 | 12 | MM15913 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 JUNB COL6A5 COL9A2 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 4.66e-15 | 532 | 32 | 16 | M27870 |
| Pathway | KEGG_FOCAL_ADHESION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 7.92e-15 | 199 | 32 | 12 | M7253 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.08e-14 | 47 | 32 | 8 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_MET | COL3A1 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 8.62e-14 | 79 | 32 | 9 | M27643 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 COL11A1 COL11A2 COL1A1 COL1A2 | 9.49e-14 | 418 | 32 | 14 | MM15587 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.52e-12 | 18 | 32 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.52e-12 | 18 | 32 | 6 | MM14882 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.62e-12 | 67 | 32 | 8 | MM15345 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.68e-12 | 43 | 32 | 7 | M39565 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.38e-11 | 27 | 32 | 6 | M27217 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 3.15e-11 | 302 | 32 | 11 | M39719 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 7.15e-11 | 326 | 32 | 11 | MM15917 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 1.80e-10 | 261 | 32 | 10 | MM15676 |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 4.94e-10 | 19 | 32 | 5 | M27221 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 4.11e-09 | 28 | 32 | 5 | MM15957 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.55e-09 | 10 | 32 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.55e-09 | 10 | 32 | 4 | MM1560 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.95e-09 | 30 | 32 | 5 | M27216 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 CACNG8 | 6.86e-09 | 502 | 32 | 11 | MM14537 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 7.13e-09 | 11 | 32 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.07e-08 | 12 | 32 | 4 | MM1526 | |
| Pathway | WP_FOCAL_ADHESION | 1.08e-08 | 199 | 32 | 8 | M39402 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.54e-08 | 13 | 32 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.54e-08 | 13 | 32 | 4 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.15e-08 | 14 | 32 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.15e-08 | 14 | 32 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.93e-08 | 15 | 32 | 4 | MM14922 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.93e-08 | 43 | 32 | 5 | M53 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.03e-07 | 20 | 32 | 4 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.88e-07 | 23 | 32 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.88e-07 | 23 | 32 | 4 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 | 3.38e-07 | 575 | 32 | 10 | M29853 |
| Pathway | WP_PI3KAKT_SIGNALING | 6.54e-07 | 339 | 32 | 8 | M39736 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 2.31e-06 | 12 | 32 | 3 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 2.31e-06 | 12 | 32 | 3 | M27352 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.54e-06 | 98 | 32 | 5 | M27152 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 8.47e-06 | 18 | 32 | 3 | M39421 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.14e-05 | 30 | 32 | 3 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.14e-05 | 30 | 32 | 3 | M39641 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.27e-05 | 96 | 32 | 4 | M39834 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.04e-04 | 7 | 32 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.39e-04 | 8 | 32 | 2 | M48236 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.94e-04 | 50 | 32 | 3 | M48087 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A5 COL9A2 CACNG8 | 1.96e-04 | 1432 | 32 | 11 | M509 |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 3.25e-04 | 12 | 32 | 2 | MM15452 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.59e-04 | 161 | 32 | 4 | M39770 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 5.87e-04 | 16 | 32 | 2 | M9450 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 8.33e-04 | 19 | 32 | 2 | M48230 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 8.94e-04 | 84 | 32 | 3 | M3228 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.45e-03 | 25 | 32 | 2 | M274 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 1.82e-03 | 28 | 32 | 2 | M42541 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 2.52e-03 | 33 | 32 | 2 | M39870 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 2.83e-03 | 35 | 32 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 2.83e-03 | 35 | 32 | 2 | M773 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 3.00e-03 | 36 | 32 | 2 | M633 | |
| Pathway | PID_FRA_PATHWAY | 3.16e-03 | 37 | 32 | 2 | M65 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.33e-03 | 38 | 32 | 2 | MM15456 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.48e-03 | 135 | 32 | 3 | MM14781 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.51e-03 | 39 | 32 | 2 | M10735 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 4.65e-03 | 45 | 32 | 2 | M39864 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 5.21e-03 | 725 | 32 | 6 | M27507 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 5.94e-03 | 51 | 32 | 2 | M665 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 6.64e-03 | 54 | 32 | 2 | M42568 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 8.94e-03 | 63 | 32 | 2 | M8 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 8.97e-03 | 190 | 32 | 3 | M8240 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL27A1 COL1A1 COL1A2 | 1.77e-29 | 175 | 39 | 17 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL3A1 COL4A1 COL4A2 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL21A1 COL1A1 COL1A2 | 3.70e-29 | 135 | 39 | 16 | 28675934 |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL13A1 ITLN2 COL25A1 COL27A1 COL1A1 COL1A2 | 1.31e-27 | 167 | 39 | 16 | 22159717 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL11A2 COL27A1 COL1A1 COL1A2 | 3.74e-27 | 62 | 39 | 13 | 28344315 |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 C1QB COL5A1 COL5A2 COL7A1 COL9A2 COL13A1 COL25A1 COL21A1 COL1A1 COL1A2 | 7.59e-24 | 153 | 39 | 14 | 25037231 | |
| Pubmed | 1.24e-18 | 25 | 39 | 8 | 19180518 | ||
| Pubmed | 1.33e-18 | 6 | 39 | 6 | 10722718 | ||
| Pubmed | 1.43e-17 | 16 | 39 | 7 | 17881772 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.71e-17 | 8 | 39 | 6 | 20059976 | |
| Pubmed | 3.71e-17 | 8 | 39 | 6 | 18816857 | ||
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 9878537 | ||
| Pubmed | 2.78e-16 | 10 | 39 | 6 | 9415455 | ||
| Pubmed | 1.36e-15 | 5 | 39 | 5 | 15365990 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 6.60e-15 | 15 | 39 | 6 | 9832566 | |
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 8.14e-15 | 6 | 39 | 5 | 17029294 | |
| Pubmed | 8.14e-15 | 6 | 39 | 5 | 21467034 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 8.14e-15 | 6 | 39 | 5 | 8563024 | |
| Pubmed | 1.89e-14 | 39 | 39 | 7 | 33580754 | ||
| Pubmed | 3.57e-14 | 19 | 39 | 6 | 15689378 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.78e-14 | 86 | 39 | 8 | 28327460 | |
| Pubmed | 7.59e-14 | 8 | 39 | 5 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 7.59e-14 | 8 | 39 | 5 | 11867580 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 7.59e-14 | 8 | 39 | 5 | 33875569 | |
| Pubmed | 1.22e-13 | 50 | 39 | 7 | 23658023 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.56e-13 | 97 | 39 | 8 | 27559042 | |
| Pubmed | 1.71e-13 | 9 | 39 | 5 | 8900172 | ||
| Pubmed | 3.41e-13 | 10 | 39 | 5 | 14559231 | ||
| Pubmed | 3.41e-13 | 10 | 39 | 5 | 2446864 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL1A1 COL1A2 | 5.43e-13 | 186 | 39 | 9 | 20673868 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL1A1 COL1A2 | 5.43e-13 | 186 | 39 | 9 | 20452482 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.07e-12 | 12 | 39 | 5 | 12180907 | |
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 33974636 | ||
| Pubmed | COL5A1 COL5A2 COL5A3 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL1A2 | 1.63e-12 | 210 | 39 | 9 | 16537572 | |
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 6.74e-12 | 5 | 39 | 4 | 14758483 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | COL3A1 COL4A1 COL4A2 C1QB COL5A1 COL5A2 COL11A1 COL1A1 COL1A2 | 7.25e-12 | 248 | 39 | 9 | 24006456 |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.02e-11 | 6 | 39 | 4 | 9506531 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 7495302 | ||
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.02e-11 | 6 | 39 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.02e-11 | 6 | 39 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.02e-11 | 6 | 39 | 4 | 6389236 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 16192629 | ||
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.02e-11 | 6 | 39 | 4 | 10534397 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 9101290 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.02e-11 | 6 | 39 | 4 | 9673377 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 17876790 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 2.02e-11 | 6 | 39 | 4 | 3571333 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.02e-11 | 6 | 39 | 4 | 19275937 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 6988303 | ||
| Pubmed | 2.73e-11 | 21 | 39 | 5 | 27856617 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 10639489 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 4.71e-11 | 7 | 39 | 4 | 8006028 | |
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 10416788 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 23273220 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 4.71e-11 | 7 | 39 | 4 | 10716744 | |
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 1724753 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 7521231 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 3997552 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 29422532 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 15872058 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 9164858 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 9.42e-11 | 8 | 39 | 4 | 10970885 | |
| Pubmed | 9.50e-11 | 64 | 39 | 6 | 22261194 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.08e-10 | 27 | 39 | 5 | 12192060 | |
| Pubmed | 1.69e-10 | 9 | 39 | 4 | 8562707 | ||
| Pubmed | 1.69e-10 | 9 | 39 | 4 | 12101409 | ||
| Pubmed | 2.68e-10 | 32 | 39 | 5 | 23154389 | ||
| Pubmed | 2.73e-10 | 146 | 39 | 7 | 27068509 | ||
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 9136074 | ||
| Pubmed | 4.43e-10 | 11 | 39 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.43e-10 | 11 | 39 | 4 | 7500359 | |
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 4.43e-10 | 11 | 39 | 4 | 20696843 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 4.43e-10 | 11 | 39 | 4 | 9731539 | |
| Pubmed | 6.64e-10 | 12 | 39 | 4 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 6.64e-10 | 12 | 39 | 4 | 15837576 | |
| Pubmed | 6.64e-10 | 12 | 39 | 4 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 9.58e-10 | 13 | 39 | 4 | 9833687 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 9.58e-10 | 13 | 39 | 4 | 21173153 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 9.58e-10 | 13 | 39 | 4 | 36335435 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34205850 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 37158802 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34691289 | ||
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 1.30e-09 | 3 | 39 | 3 | 17453912 | |
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 1.30e-09 | 3 | 39 | 3 | 1571108 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34009784 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.30e-09 | 3 | 39 | 3 | 8785585 | |
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 1.30e-09 | 3 | 39 | 3 | 15136578 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.30e-09 | 3 | 39 | 3 | 1879336 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 20301422 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26406420 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 6501291 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 7346227 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 30273997 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17662583 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 1.30e-09 | 3 | 39 | 3 | 9582436 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 36553626 | ||
| Interaction | COLGALT2 interactions | COL4A1 COL4A2 COL4A5 C1QB COL9A2 C1QTNF3 COL13A1 COL21A1 COL1A1 | 5.56e-15 | 67 | 39 | 9 | int:COLGALT2 |
| Interaction | LAIR2 interactions | 3.89e-14 | 49 | 39 | 8 | int:LAIR2 | |
| Interaction | COL4A2 interactions | 1.41e-12 | 75 | 39 | 8 | int:COL4A2 | |
| Interaction | DCN interactions | 1.76e-12 | 43 | 39 | 7 | int:DCN | |
| Interaction | MMP9 interactions | 4.60e-11 | 67 | 39 | 7 | int:MMP9 | |
| Interaction | COL1A2 interactions | 1.38e-10 | 78 | 39 | 7 | int:COL1A2 | |
| Interaction | CD93 interactions | 2.71e-10 | 45 | 39 | 6 | int:CD93 | |
| Interaction | MMP2 interactions | 3.00e-10 | 87 | 39 | 7 | int:MMP2 | |
| Interaction | TGFBI interactions | 1.07e-09 | 25 | 39 | 5 | int:TGFBI | |
| Interaction | MAG interactions | 2.39e-09 | 29 | 39 | 5 | int:MAG | |
| Interaction | SPARC interactions | 2.67e-09 | 65 | 39 | 6 | int:SPARC | |
| Interaction | COL5A1 interactions | 2.67e-09 | 65 | 39 | 6 | int:COL5A1 | |
| Interaction | PLOD1 interactions | COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL13A1 COL25A1 COL21A1 COL1A1 | 3.60e-09 | 292 | 39 | 9 | int:PLOD1 |
| Interaction | PDGFA interactions | 4.03e-09 | 32 | 39 | 5 | int:PDGFA | |
| Interaction | C1QTNF1 interactions | 3.01e-08 | 47 | 39 | 5 | int:C1QTNF1 | |
| Interaction | HABP2 interactions | 3.59e-08 | 18 | 39 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 5.67e-08 | 20 | 39 | 4 | int:OSM | |
| Interaction | PRNP interactions | RABL6 COL4A4 COL5A2 FLNA JUNB COL9A2 COL11A1 COL22A1 COL13A1 COL25A1 XRCC5 ZCCHC3 COL1A2 | 1.39e-07 | 1158 | 39 | 13 | int:PRNP |
| Interaction | THBS1 interactions | 1.53e-07 | 127 | 39 | 6 | int:THBS1 | |
| Interaction | COL5A2 interactions | 2.75e-07 | 29 | 39 | 4 | int:COL5A2 | |
| Interaction | BGN interactions | 3.16e-07 | 30 | 39 | 4 | int:BGN | |
| Interaction | FN1 interactions | COL4A1 COL4A2 COL4A4 COL4A5 C1QB FLNA COL7A1 COL13A1 XRCC5 COL1A1 COL1A2 | 3.90e-07 | 848 | 39 | 11 | int:FN1 |
| Interaction | PDGFB interactions | 7.25e-07 | 88 | 39 | 5 | int:PDGFB | |
| Interaction | COL5A3 interactions | 7.97e-07 | 10 | 39 | 3 | int:COL5A3 | |
| Interaction | SMAD3 interactions | 1.85e-06 | 447 | 39 | 8 | int:SMAD3 | |
| Interaction | BMP1 interactions | 2.30e-06 | 111 | 39 | 5 | int:BMP1 | |
| Interaction | MATN2 interactions | 2.51e-06 | 113 | 39 | 5 | int:MATN2 | |
| Interaction | SERPINE2 interactions | 4.09e-06 | 56 | 39 | 4 | int:SERPINE2 | |
| Interaction | SMAD7 interactions | 4.45e-06 | 127 | 39 | 5 | int:SMAD7 | |
| Interaction | TGM2 interactions | 5.58e-06 | 235 | 39 | 6 | int:TGM2 | |
| Interaction | FBLN2 interactions | 7.92e-06 | 66 | 39 | 4 | int:FBLN2 | |
| Interaction | TIMP2 interactions | 1.42e-05 | 277 | 39 | 6 | int:TIMP2 | |
| Interaction | COL7A1 interactions | 1.50e-05 | 25 | 39 | 3 | int:COL7A1 | |
| Interaction | ANTXR2 interactions | 2.36e-05 | 29 | 39 | 3 | int:ANTXR2 | |
| Interaction | PLOD3 interactions | 2.62e-05 | 183 | 39 | 5 | int:PLOD3 | |
| Interaction | VWF interactions | 3.20e-05 | 32 | 39 | 3 | int:VWF | |
| Interaction | C1QC interactions | 7.30e-05 | 42 | 39 | 3 | int:C1QC | |
| Interaction | COL8A2 interactions | 7.30e-05 | 42 | 39 | 3 | int:COL8A2 | |
| Interaction | LAMA5 interactions | 7.59e-05 | 117 | 39 | 4 | int:LAMA5 | |
| Interaction | VHL interactions | 8.85e-05 | 561 | 39 | 7 | int:VHL | |
| Interaction | BMP3 interactions | 1.01e-04 | 8 | 39 | 2 | int:BMP3 | |
| Interaction | NID1 interactions | 1.09e-04 | 48 | 39 | 3 | int:NID1 | |
| Interaction | MYOC interactions | 1.09e-04 | 48 | 39 | 3 | int:MYOC | |
| Interaction | COL4A1 interactions | 1.09e-04 | 48 | 39 | 3 | int:COL4A1 | |
| Interaction | DDR1 interactions | 1.14e-04 | 130 | 39 | 4 | int:DDR1 | |
| Interaction | COL12A1 interactions | 1.23e-04 | 50 | 39 | 3 | int:COL12A1 | |
| Interaction | ADAMTS5 interactions | 1.30e-04 | 9 | 39 | 2 | int:ADAMTS5 | |
| Interaction | COL21A1 interactions | 1.30e-04 | 9 | 39 | 2 | int:COL21A1 | |
| Interaction | PAX3 interactions | 1.39e-04 | 52 | 39 | 3 | int:PAX3 | |
| Interaction | SAA1 interactions | 1.55e-04 | 54 | 39 | 3 | int:SAA1 | |
| Interaction | COL2A1 interactions | 2.57e-04 | 64 | 39 | 3 | int:COL2A1 | |
| Interaction | TMEM44 interactions | 3.77e-04 | 15 | 39 | 2 | int:TMEM44 | |
| Interaction | PLOD2 interactions | 3.97e-04 | 180 | 39 | 4 | int:PLOD2 | |
| Interaction | FGF7 interactions | 4.30e-04 | 16 | 39 | 2 | int:FGF7 | |
| Interaction | NID2 interactions | 6.14e-04 | 86 | 39 | 3 | int:NID2 | |
| Interaction | CBLL2 interactions | 6.78e-04 | 20 | 39 | 2 | int:CBLL2 | |
| Interaction | MEX3A interactions | 8.27e-04 | 384 | 39 | 5 | int:MEX3A | |
| Interaction | COL18A1 interactions | 8.97e-04 | 98 | 39 | 3 | int:COL18A1 | |
| Interaction | MCPH1 interactions | 9.79e-04 | 101 | 39 | 3 | int:MCPH1 | |
| Interaction | PEG10 interactions | 1.13e-03 | 106 | 39 | 3 | int:PEG10 | |
| Cytoband | 13q34 | 9.79e-04 | 54 | 39 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 2.57e-03 | 88 | 39 | 2 | chr13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q32 | 3.98e-03 | 110 | 39 | 2 | chr2q32 | |
| GeneFamily | Collagens | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.15e-45 | 46 | 35 | 20 | 490 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.96e-03 | 34 | 35 | 2 | 487 | |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.25e-47 | 44 | 39 | 20 | M3005 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 7.43e-45 | 43 | 39 | 19 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.49e-30 | 275 | 39 | 20 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 5.31e-28 | 270 | 39 | 19 | MM17057 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 ITLN2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.99e-23 | 1026 | 39 | 23 | M5889 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 C1QB COL5A1 COL5A2 COL5A3 COL7A1 COL6A5 COL9A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 ITLN2 COL25A1 COL27A1 COL1A1 COL1A2 | 1.62e-21 | 1008 | 39 | 22 | MM17056 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 5.38e-15 | 200 | 39 | 11 | M5930 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.57e-13 | 74 | 39 | 8 | M13547 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 FLNA JUNB COL21A1 COL27A1 COL1A1 COL1A2 | 2.33e-13 | 385 | 39 | 12 | M39264 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 7.18e-13 | 23 | 39 | 6 | M48001 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.34e-12 | 64 | 39 | 7 | M2572 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 FLNA COL5A3 COL13A1 COL27A1 COL1A1 COL1A2 | 5.61e-12 | 505 | 39 | 12 | M39167 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 8.32e-12 | 120 | 39 | 8 | M42505 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.13e-11 | 71 | 39 | 7 | M3955 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.24e-11 | 126 | 39 | 8 | M39132 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.93e-11 | 81 | 39 | 7 | M39253 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 4.91e-11 | 44 | 39 | 6 | M18274 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.45e-11 | 47 | 39 | 6 | M7585 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | COL3A1 COL4A1 COL4A2 C1QB COL5A1 COL5A2 COL11A1 AHNAK2 COL1A1 COL1A2 | 7.56e-11 | 352 | 39 | 10 | M17471 |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.63e-10 | 192 | 39 | 8 | M42501 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 6.46e-10 | 29 | 39 | 5 | MM17055 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 8.12e-10 | 69 | 39 | 6 | M10165 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.79e-09 | 235 | 39 | 8 | M5311 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 2.52e-09 | 83 | 39 | 6 | M2448 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.54e-09 | 40 | 39 | 5 | M5887 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.60e-09 | 88 | 39 | 6 | M1167 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.11e-09 | 163 | 39 | 7 | M2769 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 7.33e-09 | 46 | 39 | 5 | MM544 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 7.35e-09 | 99 | 39 | 6 | M39152 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 7.81e-09 | 100 | 39 | 6 | MM514 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 8.19e-09 | 47 | 39 | 5 | M1399 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL21A1 COL1A1 COL1A2 | 9.96e-09 | 767 | 39 | 11 | M39209 |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.37e-08 | 194 | 39 | 7 | M39122 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.38e-08 | 305 | 39 | 8 | M19875 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.60e-08 | 19 | 39 | 4 | M15125 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 2.42e-08 | 58 | 39 | 5 | M178 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A2 COL5A1 FLNA COL7A1 COL13A1 COL27A1 AHNAK2 COL1A2 | 3.52e-08 | 493 | 39 | 9 | M19391 |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.32e-08 | 65 | 39 | 5 | M39309 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.17e-08 | 137 | 39 | 6 | M40313 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.44e-08 | 68 | 39 | 5 | M1373 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 6.07e-08 | 6 | 39 | 3 | M48000 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 6.14e-08 | 141 | 39 | 6 | M10381 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 6.96e-08 | 144 | 39 | 6 | M1484 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.27e-08 | 72 | 39 | 5 | MM1131 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 7.55e-08 | 146 | 39 | 6 | MM973 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 8.19e-08 | 148 | 39 | 6 | MM1010 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 8.35e-08 | 74 | 39 | 5 | M4479 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.16e-07 | 79 | 39 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.24e-07 | 80 | 39 | 5 | MM1285 | |
| Coexpression | MA_RAT_AGING_DN | 1.35e-07 | 161 | 39 | 6 | M46419 | |
| Coexpression | ZHU_CMV_24_HR_DN | 1.58e-07 | 84 | 39 | 5 | M4065 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | COL3A1 COL4A1 COL4A2 COL5A2 FLNA COL5A3 JUNB OAZ2 COL21A1 COL1A2 | 1.78e-07 | 795 | 39 | 10 | M39050 |
| Coexpression | MA_RAT_AGING_DN | 1.86e-07 | 170 | 39 | 6 | MM16097 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.12e-07 | 35 | 39 | 4 | M11788 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.37e-07 | 91 | 39 | 5 | M40180 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.38e-07 | 36 | 39 | 4 | MM1212 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 2.79e-07 | 94 | 39 | 5 | M7013 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 3.06e-07 | 185 | 39 | 6 | M42503 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.83e-07 | 316 | 39 | 7 | M2293 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 4.43e-07 | 323 | 39 | 7 | MM1066 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 4.84e-07 | 105 | 39 | 5 | M12602 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 4.98e-07 | 11 | 39 | 3 | M47997 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL1A1 COL1A2 | 5.40e-07 | 681 | 39 | 9 | M39175 |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 5.89e-07 | 337 | 39 | 7 | MM16606 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 6.38e-07 | 111 | 39 | 5 | M45685 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 6.63e-07 | 211 | 39 | 6 | M12225 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 7.77e-07 | 48 | 39 | 4 | M39318 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 8.29e-07 | 117 | 39 | 5 | M39300 | |
| Coexpression | ZHU_CMV_ALL_DN | 9.02e-07 | 119 | 39 | 5 | M14555 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 9.17e-07 | 50 | 39 | 4 | M1259 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 9.17e-07 | 50 | 39 | 4 | M7337 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 9.39e-07 | 224 | 39 | 6 | M9893 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.08e-06 | 52 | 39 | 4 | MM1118 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.08e-06 | 369 | 39 | 7 | MM16610 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.37e-06 | 15 | 39 | 3 | MM402 | |
| Coexpression | DEMAGALHAES_AGING_DN | 1.68e-06 | 16 | 39 | 3 | M2145 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.04e-06 | 17 | 39 | 3 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.04e-06 | 17 | 39 | 3 | MM1297 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.19e-06 | 62 | 39 | 4 | M16774 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.31e-06 | 144 | 39 | 5 | M5942 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.45e-06 | 18 | 39 | 3 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.45e-06 | 18 | 39 | 3 | MM1241 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.47e-06 | 146 | 39 | 5 | M40222 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.66e-06 | 268 | 39 | 6 | M45796 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 3.73e-06 | 445 | 39 | 7 | M3645 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.00e-06 | 72 | 39 | 4 | M9908 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | COL3A1 COL4A1 COL4A2 C1QB COL5A1 COL5A2 COL22A1 XRCC5 COL27A1 COL1A1 COL1A2 | 4.27e-06 | 1407 | 39 | 11 | M14427 |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 4.60e-06 | 22 | 39 | 3 | M40074 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.71e-06 | 75 | 39 | 4 | MM1084 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 5.38e-06 | 303 | 39 | 6 | M39040 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.04e-06 | 479 | 39 | 7 | M2573 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 6.13e-06 | 310 | 39 | 6 | MM16608 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.38e-06 | 483 | 39 | 7 | MM1082 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 6.52e-06 | 178 | 39 | 5 | M17079 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 7.08e-06 | 318 | 39 | 6 | M41707 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.14e-06 | 86 | 39 | 4 | M2259 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 8.31e-06 | 503 | 39 | 7 | M2226 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 9.66e-06 | 193 | 39 | 5 | M39321 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 9.75e-06 | 90 | 39 | 4 | M38984 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 1.08e-05 | 29 | 39 | 3 | M7581 | |
| CoexpressionAtlas | BM Top 100 - cervix | 2.15e-09 | 66 | 39 | 6 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.15e-09 | 66 | 39 | 6 | BM Top 100 - endometrium | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 6.57e-08 | 116 | 39 | 6 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.65e-07 | 69 | 39 | 5 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 2.05e-07 | 72 | 39 | 5 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 2.20e-07 | 73 | 39 | 5 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 2.35e-07 | 74 | 39 | 5 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL9A2 COL11A1 SLC39A5 PRDM6 COL1A1 COL1A2 | 3.53e-07 | 1094 | 39 | 12 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 COL4A1 COL4A2 COL5A1 COL5A3 COL11A1 COL11A2 COL25A1 SLC39A5 COL1A1 COL1A2 | 7.26e-07 | 951 | 39 | 11 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 8.23e-07 | 95 | 39 | 5 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL4A4 BNC1 COL4A5 COL5A1 COL9A2 COL11A1 COL13A1 AHNAK2 COL1A1 COL1A2 | 1.15e-06 | 790 | 39 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.49e-06 | 197 | 39 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | BNC1 COL5A1 COL5A2 JUNB COL22A1 COL25A1 PRDM6 ZCCHC3 COL1A1 COL1A2 | 1.93e-06 | 837 | 39 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 2.81e-06 | 498 | 39 | 8 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.04e-06 | 234 | 39 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.31e-06 | 369 | 39 | 7 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 4.68e-06 | 240 | 39 | 6 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL9A2 COL11A1 COL13A1 ITLN2 COL27A1 BAHCC1 | 4.73e-06 | 1153 | 39 | 11 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 JUNB SLC39A5 COL1A1 COL1A2 | 7.50e-06 | 761 | 39 | 9 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL3A1 COL5A1 COL5A3 COL11A1 COL25A1 COL21A1 SLC39A5 AHNAK2 COL1A1 COL1A2 | 7.91e-06 | 981 | 39 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 8.16e-06 | 70 | 39 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL3A1 COL9A2 COL11A1 COL11A2 ITLN2 COL21A1 SLC39A5 PRDM6 COL1A1 COL1A2 | 8.72e-06 | 992 | 39 | 10 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL3A1 BNC1 COL5A1 COL5A2 COL11A1 SLC39A5 PRDM6 COL1A1 BAHCC1 COL1A2 | 8.88e-06 | 994 | 39 | 10 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 8.99e-06 | 413 | 39 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 1.02e-05 | 74 | 39 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.04e-05 | 159 | 39 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL4A4 COL4A5 COL5A1 C1QTNF3 COL11A1 COL27A1 AHNAK2 COL1A1 COL1A2 | 1.11e-05 | 799 | 39 | 9 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.15e-05 | 281 | 39 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.15e-05 | 281 | 39 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 1.29e-05 | 814 | 39 | 9 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.46e-05 | 445 | 39 | 7 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.64e-05 | 453 | 39 | 7 | GSM777067_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 2.03e-05 | 88 | 39 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 2.93e-05 | 496 | 39 | 7 | Arv_EB-LF_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.96e-05 | 497 | 39 | 7 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.98e-05 | 97 | 39 | 4 | GSM777043_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 3.10e-05 | 98 | 39 | 4 | Arv_EB-LF_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.15e-05 | 336 | 39 | 6 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 3.23e-05 | 99 | 39 | 4 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | placenta | 3.90e-05 | 349 | 39 | 6 | placenta | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.48e-05 | 371 | 39 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL3A1 COL5A1 COL11A1 COL11A2 COL21A1 SLC39A5 PRDM6 COL1A1 COL1A2 | 5.82e-05 | 986 | 39 | 9 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.96e-05 | 229 | 39 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 6.97e-05 | 777 | 39 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 7.03e-05 | 778 | 39 | 8 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.54e-05 | 123 | 39 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 7.74e-05 | 395 | 39 | 6 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 8.32e-05 | 797 | 39 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 8.76e-05 | 404 | 39 | 6 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_100 | 9.14e-05 | 8 | 39 | 2 | gudmap_developingGonad_P2_epididymis_100_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 9.25e-05 | 408 | 39 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.21e-04 | 139 | 39 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.28e-04 | 433 | 39 | 6 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.35e-04 | 437 | 39 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.68e-04 | 455 | 39 | 6 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.81e-04 | 290 | 39 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.91e-04 | 466 | 39 | 6 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_200 | 2.11e-04 | 63 | 39 | 3 | gudmap_developingGonad_P2_testes_200_k4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 2.11e-04 | 300 | 39 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 2.31e-04 | 65 | 39 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 COL4A5 COL5A2 COL7A1 COL9A2 COL11A1 COL22A1 DOT1L BAHCC1 COL1A2 | 2.38e-04 | 1466 | 39 | 10 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.42e-04 | 66 | 39 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 2.48e-04 | 489 | 39 | 6 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 2.64e-04 | 68 | 39 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 2.67e-04 | 496 | 39 | 6 | PCBC_EB_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.85e-04 | 320 | 39 | 5 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - ovary | 2.88e-04 | 70 | 39 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 2.93e-04 | 175 | 39 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 3.00e-04 | 71 | 39 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 3.00e-04 | 71 | 39 | 3 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 3.13e-04 | 72 | 39 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.28e-04 | 330 | 39 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | 3.48e-04 | 982 | 39 | 8 | PCBC_ratio_MESO-5_vs_SC_1000 | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 3.53e-04 | 75 | 39 | 3 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | BM Top 100 - vagina | 3.67e-04 | 76 | 39 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - urethra | 3.81e-04 | 77 | 39 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_100 | 4.27e-04 | 80 | 39 | 3 | gudmap_developingGonad_P2_testes_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_100 | 4.59e-04 | 82 | 39 | 3 | gudmap_developingGonad_P2_epididymis_100 | |
| CoexpressionAtlas | BM Top 100 - vulva | 4.59e-04 | 82 | 39 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 4.92e-04 | 84 | 39 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 4.95e-04 | 783 | 39 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.10e-04 | 85 | 39 | 3 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.28e-04 | 86 | 39 | 3 | GSM777055_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 5.42e-04 | 206 | 39 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.46e-04 | 87 | 39 | 3 | GSM777050_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.67e-04 | 801 | 39 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 5.83e-04 | 89 | 39 | 3 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 5.83e-04 | 89 | 39 | 3 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.24e-04 | 814 | 39 | 7 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.26e-04 | 214 | 39 | 4 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 6.36e-04 | 1075 | 39 | 8 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 6.42e-04 | 92 | 39 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 6.47e-04 | 819 | 39 | 7 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.76e-04 | 591 | 39 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.50e-04 | 97 | 39 | 3 | GSM777046_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.78e-04 | 607 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_100 | 7.95e-04 | 99 | 39 | 3 | JC_fibro_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.19e-04 | 230 | 39 | 4 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 8.33e-04 | 615 | 39 | 6 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 8.41e-04 | 406 | 39 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL13A1 COL25A1 COL21A1 COL1A1 COL1A2 | 9.11e-18 | 191 | 39 | 11 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 PRDM6 COL1A1 COL1A2 | 1.08e-17 | 194 | 39 | 11 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL1A1 COL1A2 | 1.15e-17 | 195 | 39 | 11 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL11A1 PRDM6 COL27A1 COL1A1 COL1A2 | 1.29e-17 | 197 | 39 | 11 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 1.36e-17 | 198 | 39 | 11 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 1.36e-17 | 198 | 39 | 11 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.36e-17 | 198 | 39 | 11 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL21A1 PRDM6 COL27A1 COL1A1 COL1A2 | 1.44e-17 | 199 | 39 | 11 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL3A1 COL5A1 COL5A2 COL5A3 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 1.17e-16 | 157 | 39 | 10 | f147e24f2ece82e1c54750868954d09b3c461804 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL27A1 COL1A1 COL1A2 | 5.55e-16 | 183 | 39 | 10 | 803376f5260de83c48d4f7301278d078a32b3e6e |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL27A1 COL1A1 COL1A2 | 5.55e-16 | 183 | 39 | 10 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL27A1 COL1A1 COL1A2 | 5.55e-16 | 183 | 39 | 10 | cc7f5a17b40e8d901885174922e5fa8877643071 |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 C1QB COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 8.12e-16 | 190 | 39 | 10 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 PRDM6 AHNAK2 COL1A1 COL1A2 | 9.52e-16 | 193 | 39 | 10 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL11A1 PRDM6 COL27A1 COL1A1 COL1A2 | 1.06e-15 | 195 | 39 | 10 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL11A1 COL21A1 COL1A1 COL1A2 | 1.06e-15 | 195 | 39 | 10 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL11A1 COL21A1 COL1A1 COL1A2 | 1.06e-15 | 195 | 39 | 10 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL11A1 COL11A2 COL1A1 COL1A2 | 1.06e-15 | 195 | 39 | 10 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL11A1 PRDM6 COL27A1 COL1A1 COL1A2 | 1.06e-15 | 195 | 39 | 10 | 095b8e0be385b6390420589124a95fa4ba3682ab |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 JUNB COL11A1 PRDM6 COL1A1 COL1A2 | 1.11e-15 | 196 | 39 | 10 | f47e551ba484687ba6ce8c29a085106131364042 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL7A1 COL1A1 COL1A2 | 1.11e-15 | 196 | 39 | 10 | 12d9028f90c057c6e5cff00301793fa550e86c5a |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL27A1 COL1A1 COL1A2 | 1.17e-15 | 197 | 39 | 10 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL5A3 COL27A1 COL1A1 COL1A2 | 1.17e-15 | 197 | 39 | 10 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A1 COL5A2 C1QTNF3 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 1.23e-15 | 198 | 39 | 10 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA C1QTNF3 COL21A1 COL1A1 COL1A2 | 1.30e-15 | 199 | 39 | 10 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 COL1A1 COL1A2 | 1.30e-15 | 199 | 39 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL22A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | ff0b2675c68e9fc1fa16b3276431f199f3642eac |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL13A1 COL21A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL13A1 COL21A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL5A3 COL22A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL25A1 COL27A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 COL1A1 COL1A2 | 1.36e-15 | 200 | 39 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 1.25e-14 | 158 | 39 | 9 | e5636c0b608d68bd426a2b446ac508e4512e86a4 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL21A1 COL1A1 COL1A2 | 3.34e-14 | 176 | 39 | 9 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL21A1 COL1A1 COL1A2 | 3.34e-14 | 176 | 39 | 9 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL1A1 COL1A2 | 4.10e-14 | 180 | 39 | 9 | 935c091bbcd6d10b81dc4731779e5bd98205c99f |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL13A1 COL1A1 COL1A2 | 4.10e-14 | 180 | 39 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 COL11A1 COL13A1 COL1A1 COL1A2 | 4.10e-14 | 180 | 39 | 9 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 C1QTNF3 AHNAK2 COL1A1 COL1A2 | 4.31e-14 | 181 | 39 | 9 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL11A1 COL1A1 COL1A2 | 4.31e-14 | 181 | 39 | 9 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 COL5A3 COL7A1 C1QTNF3 AHNAK2 COL1A1 COL1A2 | 4.31e-14 | 181 | 39 | 9 | 6730e249cac55ae892cc567d9211615882f3dab4 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL11A1 COL1A1 COL1A2 | 4.31e-14 | 181 | 39 | 9 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL4A5 COL5A1 C1QTNF3 COL13A1 PRDM6 COL27A1 COL1A1 COL1A2 | 5.01e-14 | 184 | 39 | 9 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | COL3A1 COL4A1 COL4A2 COL5A2 COL7A1 COL13A1 COL27A1 COL1A1 COL1A2 | 5.26e-14 | 185 | 39 | 9 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL21A1 COL1A1 COL1A2 | 5.53e-14 | 186 | 39 | 9 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL27A1 COL1A2 | 5.80e-14 | 187 | 39 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL13A1 COL1A1 COL1A2 | 6.09e-14 | 188 | 39 | 9 | f16ff998393bf1954bbf10caab15173bdb104ac1 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL27A1 COL1A1 COL1A2 | 6.09e-14 | 188 | 39 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 PRDM6 COL27A1 COL1A1 COL1A2 | 6.39e-14 | 189 | 39 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | COL3A1 COL5A1 COL5A2 FLNA COL13A1 COL25A1 COL27A1 COL1A1 COL1A2 | 6.39e-14 | 189 | 39 | 9 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL25A1 COL27A1 COL1A1 COL1A2 | 6.39e-14 | 189 | 39 | 9 | c734e5693808a0333139e87bd5be2597a9252afe |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | COL3A1 COL4A4 COL5A1 COL5A2 COL7A1 C1QTNF3 AHNAK2 COL1A1 COL1A2 | 6.70e-14 | 190 | 39 | 9 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL25A1 COL27A1 COL1A1 COL1A2 | 6.70e-14 | 190 | 39 | 9 | 2e592323085ba9c019d678ac2a784462ab470ed9 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL25A1 COL27A1 COL1A1 COL1A2 | 6.70e-14 | 190 | 39 | 9 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL25A1 COL27A1 COL1A1 COL1A2 | 7.03e-14 | 191 | 39 | 9 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 COL5A3 C1QTNF3 COL11A1 AHNAK2 COL1A1 COL1A2 | 7.03e-14 | 191 | 39 | 9 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A4 COL5A1 COL5A2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.37e-14 | 192 | 39 | 9 | 9093a9e94a25682d109a7f6edc256a25a61103a0 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A4 COL5A1 COL5A2 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.37e-14 | 192 | 39 | 9 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 7.37e-14 | 192 | 39 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 7.37e-14 | 192 | 39 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA AHNAK2 COL1A1 COL1A2 | 7.73e-14 | 193 | 39 | 9 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 7.73e-14 | 193 | 39 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 7.73e-14 | 193 | 39 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 COL5A3 C1QTNF3 COL11A1 AHNAK2 COL1A1 COL1A2 | 7.73e-14 | 193 | 39 | 9 | 051f61156b0e2e95292b2d8377faf3190b50f264 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 PRDM6 COL1A1 COL1A2 | 8.10e-14 | 194 | 39 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL13A1 PRDM6 COL1A1 COL1A2 | 8.10e-14 | 194 | 39 | 9 | 749dd8113ef260e00facac09de9861d61725124a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL5A1 COL5A2 FLNA COL25A1 COL21A1 PRDM6 COL1A1 COL1A2 | 8.10e-14 | 194 | 39 | 9 | ebb038f94f49f5c655578d1b018676e10c6b7e3c |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A2 FLNA COL25A1 COL21A1 COL1A2 | 8.49e-14 | 195 | 39 | 9 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | COL3A1 COL5A1 COL5A2 FLNA COL13A1 PRDM6 COL27A1 COL1A1 COL1A2 | 8.49e-14 | 195 | 39 | 9 | 6180309c6ae278b996fd98c57461cbc129c028ba |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A2 FLNA COL25A1 COL21A1 COL1A2 | 8.49e-14 | 195 | 39 | 9 | 4f70157d42a16ff0259bc24a62803c4df4285c44 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL5A1 COL5A2 FLNA COL25A1 COL21A1 COL1A1 COL1A2 | 8.89e-14 | 196 | 39 | 9 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL6A5 COL13A1 COL1A1 COL1A2 | 8.89e-14 | 196 | 39 | 9 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-14 | 196 | 39 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 FLNA COL13A1 PRDM6 COL27A1 COL1A1 COL1A2 | 8.89e-14 | 196 | 39 | 9 | ace167a40adb7022b365be3c2b1cbd4ba963739a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-14 | 196 | 39 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 BNC1 COL5A1 COL5A2 COL5A3 COL1A1 COL1A2 | 8.89e-14 | 196 | 39 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL5A2 FLNA COL13A1 PRDM6 COL27A1 COL1A1 COL1A2 | 9.31e-14 | 197 | 39 | 9 | e3053ef8f604b6892c21c03e12612b49d3d30f23 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A2 FLNA COL25A1 COL21A1 COL1A1 COL1A2 | 9.31e-14 | 197 | 39 | 9 | 80e153790cef37b743e22a7370ff5b3a6abf147d |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 1f956e369e00d37835095a001db4b62a79014532 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL25A1 COL21A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 79576525a10ed3e3a9d1608077cd16ecda23376f |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A1 COL5A2 COL9A2 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL5A1 COL5A2 COL9A2 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A5 COL5A1 COL5A2 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL5A1 COL5A2 COL9A2 COL11A1 COL11A2 COL27A1 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL21A1 PRDM6 COL1A1 COL1A2 | 9.75e-14 | 198 | 39 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 C1QTNF3 COL21A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 84545ced0c792bc77980a50d65e484eab648d47e |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL11A1 COL13A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 12133087eae9f0e9b6c13a71e8187117768e64ce |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL27A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | ec74ff85d6b61013b1f785b2fca343759feb7843 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL21A1 PRDM6 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | COL3A1 COL5A1 COL5A2 COL5A3 COL6A5 COL13A1 PRDM6 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 COL5A3 COL11A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 63eb2106bb6e2e33d020628583536c8d96662c84 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL13A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 FLNA COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | 3368c0a90a47c4dcdfe70be3192550df0744e508 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 1.02e-13 | 199 | 39 | 9 | bf138cc692df727e087d140c014149ee5da00d9d |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 COL1A1 COL1A2 | 1.07e-13 | 200 | 39 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL5A1 COL5A2 COL6A5 COL13A1 COL21A1 COL1A1 COL1A2 | 1.07e-13 | 200 | 39 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL5A1 COL5A2 COL11A1 COL22A1 COL11A2 COL13A1 COL1A1 COL1A2 | 1.07e-13 | 200 | 39 | 9 | 780d47f8eff630020dfae32218de495a7e9dbad6 |
| Computational | Adhesion molecules. | COL3A1 COL4A1 COL4A5 COL5A1 COL5A2 COL7A1 COL9A2 COL11A1 COL1A1 | 1.52e-11 | 141 | 25 | 9 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.23e-09 | 50 | 25 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of CDH11 | 2.29e-09 | 25 | 25 | 5 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 1.60e-08 | 36 | 25 | 5 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.79e-08 | 50 | 25 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Spinal cord (neuro-development) genes. | 9.61e-07 | 360 | 25 | 8 | MODULE_12 | |
| Computational | Ovary genes. | 1.14e-06 | 368 | 25 | 8 | MODULE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.88e-06 | 50 | 25 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.88e-06 | 50 | 25 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Placenta genes. | 6.31e-06 | 463 | 25 | 8 | MODULE_38 | |
| Computational | ECM and collagens. | 9.99e-06 | 225 | 25 | 6 | MODULE_47 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 5.59e-05 | 453 | 25 | 7 | MODULE_24 | |
| Computational | Bone remodeling. | 2.55e-04 | 54 | 25 | 3 | MODULE_234 | |
| Computational | Lung genes. | 3.85e-04 | 434 | 25 | 6 | MODULE_5 | |
| Computational | Genes in the cancer module 55. | 4.10e-04 | 832 | 25 | 8 | MODULE_55 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 4.20e-04 | 835 | 25 | 8 | MODULE_88 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.67e-03 | 384 | 25 | 5 | MODULE_2 | |
| Computational | Genes in the cancer module 318. | 1.89e-03 | 28 | 25 | 2 | MODULE_318 | |
| Computational | Genes in the cancer module 229. | 2.32e-03 | 31 | 25 | 2 | MODULE_229 | |
| Computational | Genes in the cancer module 153. | 2.78e-03 | 34 | 25 | 2 | MODULE_153 | |
| Computational | Adrenal gland - metabolic genes. | 5.56e-03 | 314 | 25 | 4 | MODULE_19 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.94e-03 | 50 | 25 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.94e-03 | 50 | 25 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.94e-03 | 50 | 25 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | Developmental processes. | 6.84e-03 | 333 | 25 | 4 | MODULE_220 | |
| Drug | GK-101 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.86e-34 | 36 | 39 | 15 | CID000161853 |
| Drug | Madecassol | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.16e-32 | 46 | 39 | 15 | CID000108062 |
| Drug | d-indobufen | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.14e-31 | 50 | 39 | 15 | CID000044562 |
| Drug | ridogrel | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.23e-31 | 52 | 39 | 15 | CID005362391 |
| Drug | NSC49633 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.68e-31 | 53 | 39 | 15 | CID000023340 |
| Drug | AC1LAKND | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.28e-29 | 62 | 39 | 15 | CID000470146 |
| Drug | BAPN | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.25e-28 | 71 | 39 | 15 | CID000001647 |
| Drug | malotilate | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.25e-28 | 71 | 39 | 15 | CID000004006 |
| Drug | DMSe | COL3A1 COL4A1 COL4A5 COL5A1 FLNA COL5A3 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.49e-28 | 132 | 39 | 17 | CID000020796 |
| Drug | AC1NMZ1B | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.10e-28 | 75 | 39 | 15 | CID005034185 |
| Drug | strontium ranelate | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 4.78e-28 | 77 | 39 | 15 | CID006918182 |
| Drug | hydroxylysine | COL3A1 COL4A1 COL4A5 C1QB COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.30e-28 | 109 | 39 | 16 | CID000001029 |
| Drug | halofuginone lactate | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.42e-27 | 85 | 39 | 15 | CID000062891 |
| Drug | 4-hydroxyproline | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.33e-27 | 91 | 39 | 15 | CID000000825 |
| Drug | ticlopidine | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 5.40e-26 | 103 | 39 | 15 | CID000005472 |
| Drug | AC1L1C2F | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.54e-25 | 110 | 39 | 15 | CID000001711 |
| Drug | PPACK | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.37e-25 | 113 | 39 | 15 | CID003036757 |
| Drug | AC1L9732 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.72e-25 | 114 | 39 | 15 | CID000439300 |
| Drug | Tranilast sodium | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.13e-25 | 115 | 39 | 15 | CID000005527 |
| Drug | Selara | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.17e-24 | 125 | 39 | 15 | CID000150310 |
| Drug | pirfenidone | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 5.56e-24 | 138 | 39 | 15 | CID000040632 |
| Drug | DL-penicillamine | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.23e-24 | 139 | 39 | 15 | CID000004727 |
| Drug | PCR 4099 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.23e-24 | 139 | 39 | 15 | CID000002806 |
| Drug | candesartan cilexetil | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.21e-23 | 145 | 39 | 15 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.79e-23 | 162 | 39 | 15 | CID000072363 |
| Drug | khellin | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.57e-22 | 171 | 39 | 15 | CID000003828 |
| Drug | AC1L1DD6 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.18e-22 | 179 | 39 | 15 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.36e-22 | 189 | 39 | 15 | CID000001413 |
| Drug | foscarnet | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.98e-22 | 190 | 39 | 15 | CID000003414 |
| Drug | AC1Q6PCP | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.49e-20 | 230 | 39 | 15 | CID000005267 |
| Drug | prostacyclin sodium salt | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 5.30e-20 | 250 | 39 | 15 | CID000000159 |
| Drug | hyaluronan | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.14e-19 | 263 | 39 | 15 | CID000024759 |
| Drug | silibinin | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.85e-19 | 285 | 39 | 15 | CID000005213 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.66e-18 | 314 | 39 | 15 | CID000447989 |
| Drug | AC1L18QD | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.78e-18 | 325 | 39 | 15 | CID000000213 |
| Drug | losartan | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.66e-17 | 378 | 39 | 15 | CID000003961 |
| Drug | NC-4 | COL3A1 COL5A1 COL9A2 COL11A1 COL11A2 COL13A1 COL21A1 COL27A1 COL1A1 | 3.19e-17 | 44 | 39 | 9 | CID006420119 |
| Drug | colchine | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.24e-17 | 383 | 39 | 15 | CID000002833 |
| Drug | L-3,4-dehydroproline | COL3A1 COL5A1 COL7A1 COL11A1 COL22A1 COL13A1 COL25A1 COL21A1 COL1A1 COL1A2 | 3.57e-17 | 73 | 39 | 10 | CID000094284 |
| Drug | chondroitin sulfate | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.95e-17 | 413 | 39 | 15 | CID000024766 |
| Drug | Y-27632 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.91e-16 | 444 | 39 | 15 | CID000005711 |
| Drug | isodesmosine | 4.63e-16 | 33 | 39 | 8 | CID000013811 | |
| Drug | AC1L1KMJ | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.13e-16 | 476 | 39 | 15 | CID000030956 |
| Drug | 351A | 1.87e-15 | 20 | 39 | 7 | CID000122144 | |
| Drug | aspirin | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.56e-15 | 563 | 39 | 15 | CID000002244 |
| Drug | desmosine | 2.89e-14 | 53 | 39 | 8 | CID000025435 | |
| Drug | BPAT-143 | 6.77e-14 | 6 | 39 | 5 | CID000146249 | |
| Drug | pyridinoline | COL3A1 COL5A1 COL9A2 COL11A1 COL11A2 COL21A1 COL27A1 COL1A1 COL1A2 | 7.29e-14 | 99 | 39 | 9 | CID000105068 |
| Drug | LMWH | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.03e-13 | 663 | 39 | 15 | CID000000772 |
| Drug | PD123177 | 7.54e-13 | 43 | 39 | 7 | CID000114899 | |
| Drug | LS-63783 | COL3A1 COL4A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL25A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.66e-12 | 804 | 39 | 15 | CID000000231 |
| Drug | 1h00 | 5.34e-12 | 56 | 39 | 7 | CID000445950 | |
| Drug | 4-aminoazobenzene | 1.77e-11 | 66 | 39 | 7 | CID000006051 | |
| Drug | Sirius red | 2.64e-11 | 35 | 39 | 6 | CID005486818 | |
| Drug | AC1MRIIV | 5.28e-11 | 39 | 39 | 6 | CID003518584 | |
| Drug | dermatan sulfate | COL3A1 COL4A5 COL5A1 COL9A2 COL11A1 COL11A2 COL21A1 COL27A1 COL1A1 | 1.03e-10 | 220 | 39 | 9 | CID000032756 |
| Drug | trapidil | 5.75e-10 | 57 | 39 | 6 | CID000005531 | |
| Drug | AC1Q641C | 9.68e-10 | 62 | 39 | 6 | CID000005005 | |
| Drug | homocystine | 5.38e-09 | 82 | 39 | 6 | CID000010010 | |
| Drug | mitomycin C | 6.50e-09 | 241 | 39 | 8 | CID000005746 | |
| Drug | Curcumin | COL3A1 COL4A1 COL4A2 COL4A5 C1QB COL5A1 COL5A2 JUNB XRCC5 COL27A1 COL1A1 COL1A2 | 1.05e-08 | 850 | 39 | 12 | ctd:D003474 |
| Drug | AC1L9HPX | 1.08e-08 | 92 | 39 | 6 | CID000445279 | |
| Drug | sodium chloride | COL3A1 COL4A5 COL5A1 COL7A1 COL9A2 COL11A1 COL13A1 ITLN2 COL25A1 COL21A1 COL1A1 COL1A2 | 1.27e-08 | 865 | 39 | 12 | CID000000206 |
| Drug | 1zd2 | 1.31e-08 | 45 | 39 | 5 | CID004149241 | |
| Drug | Collagenase | 1.86e-08 | 4 | 39 | 3 | DB00048 | |
| Drug | fluoride | 1.98e-08 | 278 | 39 | 8 | CID000014917 | |
| Drug | 2,3-pentanedione | 8.24e-08 | 129 | 39 | 6 | ctd:C013186 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 9.26e-08 | 6 | 39 | 3 | ctd:C502971 | |
| Drug | calcium phosphate | 1.94e-07 | 149 | 39 | 6 | CID000024441 | |
| Drug | isocycloheximide | COL3A1 COL5A1 COL5A3 COL7A1 JUNB COL11A1 COL11A2 COL21A1 COL27A1 COL1A1 COL1A2 | 2.22e-07 | 905 | 39 | 11 | CID000002900 |
| Drug | Paclitaxel | COL3A1 COL4A1 COL4A2 C1QB COL5A2 COL7A1 COL11A2 XRCC5 COL1A1 COL1A2 | 2.60e-07 | 720 | 39 | 10 | ctd:D017239 |
| Drug | angiotensin | 4.55e-07 | 282 | 39 | 7 | CID003083715 | |
| Drug | n-butoxyethanol | 4.62e-07 | 581 | 39 | 9 | ctd:C017096 | |
| Drug | D3273 | 5.55e-07 | 94 | 39 | 5 | CID005464587 | |
| Drug | pyrachlostrobin | COL4A1 COL4A5 C1QB COL5A1 COL5A2 FLNA COL5A3 COL11A1 COL22A1 COL1A1 | 7.74e-07 | 811 | 39 | 10 | ctd:C513428 |
| Drug | Sialic acids | 1.28e-06 | 329 | 39 | 7 | CID000349960 | |
| Drug | 1-Naphthylisothiocyanate | COL3A1 COL4A1 COL4A2 C1QB COL5A1 COL5A2 FLNA GCGR COL1A1 COL1A2 | 1.48e-06 | 871 | 39 | 10 | ctd:D015058 |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 1.88e-06 | 52 | 39 | 4 | ctd:C573693 | |
| Drug | ascorbate-2-phosphate | 2.08e-06 | 15 | 39 | 3 | ctd:C011669 | |
| Drug | Vancomycin | COL3A1 COL4A1 COL4A2 C1QB COL5A2 FLNA GCGR C1QTNF3 SLC39A5 COL1A2 | 2.11e-06 | 906 | 39 | 10 | ctd:D014640 |
| Drug | 5'-methylthioadenosine | 2.86e-06 | 2 | 39 | 2 | ctd:C008500 | |
| Drug | amphotericin B, deoxycholate drug combination | 3.26e-06 | 379 | 39 | 7 | ctd:C059765 | |
| Drug | Trinitrobenzenesulfonic Acid | 4.35e-06 | 396 | 39 | 7 | ctd:D014302 | |
| Drug | aldosterone | 4.42e-06 | 397 | 39 | 7 | CID000005839 | |
| Drug | Simvastatin | 5.25e-06 | 581 | 39 | 8 | ctd:D019821 | |
| Drug | A0395 | 8.18e-06 | 75 | 39 | 4 | CID009906466 | |
| Drug | gluconate | 8.76e-06 | 287 | 39 | 6 | CID000000604 | |
| Drug | selenomethylselenocysteine | 9.57e-06 | 78 | 39 | 4 | ctd:C002979 | |
| Drug | Dimethylnitrosamine | 1.20e-05 | 865 | 39 | 9 | ctd:D004128 | |
| Drug | paricalcitol | 1.48e-05 | 87 | 39 | 4 | ctd:C084656 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 1.69e-05 | 90 | 39 | 4 | CID015942693 | |
| Drug | ATFP | 1.71e-05 | 4 | 39 | 2 | CID000193783 | |
| Drug | 17-isoprogesterone | COL3A1 COL4A5 COL5A1 COL7A1 COL11A1 COL11A2 COL21A1 COL27A1 COL1A1 COL1A2 | 2.00e-05 | 1170 | 39 | 10 | CID000004920 |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 2.02e-05 | 31 | 39 | 3 | ctd:C577942 | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.19e-05 | 199 | 39 | 5 | 5644_DN | |
| Drug | Saralasin | 2.85e-05 | 5 | 39 | 2 | ctd:D012504 | |
| Drug | rhamnose | 2.96e-05 | 356 | 39 | 6 | CID000000840 | |
| Drug | AC1L3XKP | 3.47e-05 | 37 | 39 | 3 | CID000123931 | |
| Drug | ethylnylestradiol | COL3A1 COL4A5 COL5A1 COL7A1 JUNB COL11A2 COL21A1 COL27A1 COL1A1 COL1A2 | 3.56e-05 | 1251 | 39 | 10 | CID000003285 |
| Drug | arabinosyladenine | 3.72e-05 | 762 | 39 | 8 | CID000000191 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | COL3A1 COL4A1 COL4A5 COL5A1 COL5A2 FLNA COL9A2 COL11A1 COL1A1 COL1A2 | 8.66e-20 | 53 | 39 | 10 | C4707243 |
| Disease | Ehlers-Danlos syndrome | 1.82e-10 | 8 | 39 | 4 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 3.27e-10 | 9 | 39 | 4 | DOID:13359 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.13e-09 | 3 | 39 | 3 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.13e-09 | 3 | 39 | 3 | C0220679 | |
| Disease | Early Pregnancy Loss | 6.53e-09 | 109 | 39 | 6 | C3830362 | |
| Disease | Miscarriage | 6.53e-09 | 109 | 39 | 6 | C4552766 | |
| Disease | Spontaneous abortion | 6.53e-09 | 109 | 39 | 6 | C0000786 | |
| Disease | Abortion, Tubal | 6.53e-09 | 109 | 39 | 6 | C0000822 | |
| Disease | Stickler syndrome | 2.13e-08 | 5 | 39 | 3 | cv:C0265253 | |
| Disease | Ehlers-Danlos Syndrome | 2.13e-08 | 5 | 39 | 3 | C0013720 | |
| Disease | Disproportionate short stature | 5.70e-08 | 77 | 39 | 5 | C0878659 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 7.44e-08 | 7 | 39 | 3 | C1846545 | |
| Disease | Bleeding tendency | 7.44e-08 | 7 | 39 | 3 | C1458140 | |
| Disease | Liver Cirrhosis | 2.46e-07 | 103 | 39 | 5 | C0023890 | |
| Disease | Fibrosis, Liver | 2.71e-07 | 105 | 39 | 5 | C0239946 | |
| Disease | collagen disease (implicated_via_orthology) | 4.66e-07 | 12 | 39 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.86e-07 | 48 | 39 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 5.88e-07 | 774 | 39 | 9 | C0023893 | |
| Disease | Blood Coagulation Disorders | 1.18e-06 | 16 | 39 | 3 | C0005779 | |
| Disease | Hereditary hearing loss and deafness | 1.39e-06 | 146 | 39 | 5 | cv:C0236038 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 1.70e-06 | 2 | 39 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | Ehlers-Danlos syndrome type 1 | 1.70e-06 | 2 | 39 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 1.70e-06 | 2 | 39 | 2 | C0268336 | |
| Disease | Fibrochondrogenesis | 1.70e-06 | 2 | 39 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 1.70e-06 | 2 | 39 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 1.70e-06 | 2 | 39 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 1.70e-06 | 2 | 39 | 2 | C0302892 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 1.70e-06 | 2 | 39 | 2 | C0268345 | |
| Disease | Porencephaly | 1.70e-06 | 2 | 39 | 2 | C4082173 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 1.70e-06 | 2 | 39 | 2 | C4551623 | |
| Disease | PORENCEPHALY, FAMILIAL | 1.70e-06 | 2 | 39 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.70e-06 | 2 | 39 | 2 | C3281105 | |
| Disease | Ehlers-Danlos syndrome classic type | 1.70e-06 | 2 | 39 | 2 | C4225429 | |
| Disease | Ehlers-Danlos syndrome, classic type | 1.70e-06 | 2 | 39 | 2 | cv:C4225429 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 1.70e-06 | 2 | 39 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.70e-06 | 2 | 39 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.70e-06 | 2 | 39 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 1.70e-06 | 2 | 39 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 1.70e-06 | 2 | 39 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 1.70e-06 | 2 | 39 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 1.70e-06 | 2 | 39 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 1.70e-06 | 2 | 39 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 1.70e-06 | 2 | 39 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 1.70e-06 | 2 | 39 | 2 | 259420 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.04e-06 | 19 | 39 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 2.40e-06 | 20 | 39 | 3 | C0026760 | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 5.10e-06 | 3 | 39 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 5.10e-06 | 3 | 39 | 2 | cv:C3281105 | |
| Disease | Alport syndrome | 5.10e-06 | 3 | 39 | 2 | cv:C1567741 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 5.10e-06 | 3 | 39 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | Collagen IV-related nephropathies | 5.10e-06 | 3 | 39 | 2 | cv:CN076135 | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 5.10e-06 | 3 | 39 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 5.10e-06 | 3 | 39 | 2 | 614519 | |
| Disease | Nephrotic Syndrome | 6.11e-06 | 27 | 39 | 3 | C0027726 | |
| Disease | Hematuria, Benign Familial | 1.02e-05 | 4 | 39 | 2 | C0241908 | |
| Disease | OSTEOPOROSIS | 1.02e-05 | 4 | 39 | 2 | 166710 | |
| Disease | Alport Syndrome | 1.02e-05 | 4 | 39 | 2 | C1567741 | |
| Disease | Keloid | 1.36e-05 | 35 | 39 | 3 | C0022548 | |
| Disease | Stickler syndrome, type 1 | 1.70e-05 | 5 | 39 | 2 | C2020284 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 1.70e-05 | 5 | 39 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 1.70e-05 | 5 | 39 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 1.70e-05 | 5 | 39 | 2 | C0023931 | |
| Disease | Alport Syndrome, X-Linked | 1.70e-05 | 5 | 39 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.70e-05 | 5 | 39 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.70e-05 | 5 | 39 | 2 | C1567744 | |
| Disease | Osteoporosis | 2.54e-05 | 6 | 39 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 2.54e-05 | 6 | 39 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Intervertebral disc disorder | 2.54e-05 | 6 | 39 | 2 | C0158252 | |
| Disease | Fibrosis | 4.01e-05 | 50 | 39 | 3 | C0016059 | |
| Disease | Cirrhosis | 4.01e-05 | 50 | 39 | 3 | C1623038 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 6.09e-05 | 9 | 39 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Hematuria | 6.09e-05 | 9 | 39 | 2 | C0018965 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 7.61e-05 | 10 | 39 | 2 | C0268363 | |
| Disease | Nephrosclerosis | 9.29e-05 | 11 | 39 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 9.29e-05 | 11 | 39 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 9.29e-05 | 11 | 39 | 2 | C0268362 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.11e-04 | 12 | 39 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 1.11e-04 | 12 | 39 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Connective Tissue Diseases | 1.32e-04 | 13 | 39 | 2 | C0009782 | |
| Disease | Osteogenesis Imperfecta | 1.32e-04 | 13 | 39 | 2 | C0029434 | |
| Disease | Cleft Palate | 1.70e-04 | 81 | 39 | 3 | C0008925 | |
| Disease | Disorder of eye | 1.75e-04 | 212 | 39 | 4 | C0015397 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.02e-04 | 16 | 39 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.02e-04 | 16 | 39 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 2.02e-04 | 16 | 39 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.02e-04 | 16 | 39 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.02e-04 | 16 | 39 | 2 | C3541456 | |
| Disease | osteoarthritis | 2.09e-04 | 222 | 39 | 4 | MONDO_0005178 | |
| Disease | Van Buchem disease | 2.29e-04 | 17 | 39 | 2 | C0432272 | |
| Disease | Oral Submucous Fibrosis | 2.57e-04 | 18 | 39 | 2 | C0029172 | |
| Disease | Dyschondroplasias | 2.87e-04 | 19 | 39 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 2.87e-04 | 19 | 39 | 2 | C0029422 | |
| Disease | Osteogenesis imperfecta | 3.52e-04 | 21 | 39 | 2 | cv:C0029434 | |
| Disease | Renal glomerular disease | 4.23e-04 | 23 | 39 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 4.23e-04 | 23 | 39 | 2 | C4521256 | |
| Disease | Left Ventricular Hypertrophy | 5.01e-04 | 25 | 39 | 2 | C0149721 | |
| Disease | Heart valve disease | 5.42e-04 | 26 | 39 | 2 | C0018824 | |
| Disease | Cerebral Hemorrhage | 6.30e-04 | 28 | 39 | 2 | C2937358 | |
| Disease | spontaneous coronary artery dissection | 7.73e-04 | 31 | 39 | 2 | EFO_0010820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGTGPGLPRGAHKLL | 2201 | Q9P281 | |
| EGKVLGFGHGVPDPG | 16 | Q86SG2 | |
| GGLGKPFPEGERPCH | 596 | Q01954 | |
| HGRDGHAGEKGDPGP | 586 | P53420 | |
| APGLSGSDGHKGRPG | 696 | P53420 | |
| KGPKGREGHAGFPGV | 806 | P53420 | |
| GFHRGEPGEKGQPGP | 1011 | P53420 | |
| PGRKGDRGDPGQHGL | 511 | P08572 | |
| PGLKGQRGFPGDAGL | 626 | P08572 | |
| FFGIPGLKGLAGEPG | 951 | P08572 | |
| RGLHGLPGTKGFPGS | 1196 | P08572 | |
| HPRKGFPGSLSGADG | 1291 | Q8TEK3 | |
| VGAPGLPGEKGDHGF | 896 | P02462 | |
| LPGEKGDHGFPGSSG | 901 | P02462 | |
| ELEAFLGGGAPGGRH | 706 | Q3YEC7 | |
| HPLSKIPGGRGGGRD | 36 | O95190 | |
| AKGDRGFDGLPGLPG | 596 | P12107 | |
| GFDGLPGLPGDKGHR | 601 | P12107 | |
| HGPAGPKGERGEKGA | 561 | Q9BXS0 | |
| HGPPSKELQFGRGGG | 441 | P47871 | |
| DGLPGLPGEKGHRGD | 561 | P13942 | |
| GEPGARGPQGHFGAK | 1126 | P13942 | |
| LFPHGGAGPLKGSGA | 26 | Q9NQX0 | |
| DLGPRGERGQHGPKG | 91 | Q9BXJ4 | |
| PGLPGFKGIRGHNGL | 171 | P08123 | |
| GERGLHGEFGLPGPA | 571 | P08123 | |
| PGRDGQPGHKGERGY | 936 | P08123 | |
| PHRGGGGASEKKDPG | 66 | Q8WXS5 | |
| FKIRVGEPGHGGDPG | 2416 | P21333 | |
| GCHGFPGIKGEKGDP | 1476 | A8TX70 | |
| EKGERGFPGLEGHPG | 46 | P29400 | |
| GFKGALGPKGDRGFP | 766 | P29400 | |
| GKRGILGDPGHQGKP | 196 | Q14055 | |
| DGDKGDRGLPGFPGL | 511 | Q96P44 | |
| EKGLPGLAGDHGEFG | 61 | P02746 | |
| HGEFGEKGDPGIPGN | 71 | P02746 | |
| GAPGLPGLKGHRGHK | 291 | P05997 | |
| PGLKGHRGHKGLEGP | 296 | P05997 | |
| GKEGPPGLRGDPGSH | 936 | P05997 | |
| PGPQGPRGDKGDHGD | 1121 | P05997 | |
| PKGDRGFDGLAGLPG | 626 | P20908 | |
| GFDGLAGLPGEKGHR | 631 | P20908 | |
| AGLPGEKGHRGDPGP | 636 | P20908 | |
| GLKGDRGDPGPDGEH | 1201 | Q8IZC6 | |
| ARGPPGFKGHTGDSG | 1271 | Q8NFW1 | |
| GFKGHTGDSGAPGPR | 1276 | Q8NFW1 | |
| HCIGGGGFFPQGKPR | 276 | Q8WWU7 | |
| GAAGIKGHRGFPGNP | 1101 | P02461 | |
| AGPPGRPGLAGHKGE | 2646 | Q02388 | |
| GLPGLHGPPGDKGNR | 661 | Q5TAT6 | |
| PGLPGEKGQRGDFGH | 556 | P25940 | |
| KDGRPGHPGQRGELG | 891 | P25940 | |
| EGRHAGPGGLPEKDL | 271 | Q6ZMH5 | |
| LPEGPLPEGAGFKGH | 1726 | Q8IVF2 | |
| GIKGHRGFSGLQGPP | 1106 | P02452 | |
| HRLKPPGGLGGGLGI | 221 | Q9Y330 | |
| GEGGVRHLPGAFFLG | 306 | Q9NUD5 | |
| GDRGDGPFRLGGHGP | 176 | P13010 | |
| PFAGGHPAQLGLGRG | 221 | P17275 |